ONTOLOGY REPORT - ANNOTATIONS
| Term: | N-nitrosodiethylamine |
|
| Accession: | CHEBI:34873
|
browse the term
|
| Definition: | A nitrosamine that has formula C4H10N2O. |
| Synonyms: | exact_synonym: | N-ethyl-N-nitrosoethanamine |
| | related_synonym: | 1,1-diethyl-2-oxohydrazine; C4H10N2O; CCN(CC)N=O; DANA; DEN; Diethylnitrosamine; InChI=1S/C4H10N2O/c1-3-6(4-2)5-7/h3-4H2,1-2H3; InChIKey=WBNQDOYYEUMPFS-UHFFFAOYSA-N; N,N-diethylnitrosamine; N,N-diethylnitrosoamine; NDEA; diethylnitrosoamine |
| | xref_casrn: | 55-18-5 |
| | xref: | Beilstein:1744991 "Beilstein Registry Number"; ChEMBL:374889 "ChEMBL COMPOUND"; ChemIDplus:55-18-5 "CAS Registry Number"; KEGG COMPOUND:55-18-5 "CAS Registry Number"; KEGG COMPOUND:C14422 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D004052 |
| | xref: | NIST Chemistry WebBook:55-18-5 "CAS Registry Number" |
|
|
N-nitrosodiethylamine
|
| G |
Ass1 |
argininosuccinate synthase 1 |
|
increases expression |
EXP |
3 |
10,578,717 |
10,622,332 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
multiple interactions |
EXP |
3 |
10,578,717 |
10,622,332 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
multiple interactions |
ISO |
3 |
56,403,676 |
56,496,473 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
affects expression |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
multiple interactions |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
multiple interactions |
ISO |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 (tax-responsive enhancer element B67) |
|
multiple interactions |
EXP |
7 |
118,537,718 |
118,538,994 |
RGD:6480464 |
CTD |
| G |
Atf5 |
activating transcription factor 5 |
|
multiple interactions |
EXP |
1 |
95,284,505 |
95,286,786 |
RGD:6480464 |
CTD |
| G |
Atic |
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
|
multiple interactions |
EXP |
9 |
70,676,744 |
70,696,865 |
RGD:6480464 |
CTD |
| G |
Atl2 |
atlastin GTPase 2 |
|
multiple interactions |
EXP |
6 |
2,728,722 |
2,771,082 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
multiple interactions |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
multiple interactions |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
increases expression |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
increases phosphorylation |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
multiple interactions |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
multiple interactions |
EXP |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
decreases activity |
EXP |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
multiple interactions |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
decreases expression |
EXP |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atox1 |
ATX1 antioxidant protein 1 homolog (yeast) |
|
increases expression |
EXP |
10 |
40,858,190 |
40,873,226 |
RGD:6480464 |
CTD |
| G |
Atox1 |
ATX1 antioxidant protein 1 homolog (yeast) |
|
multiple interactions |
EXP |
10 |
40,858,190 |
40,873,226 |
RGD:6480464 |
CTD |
| G |
Atp11c |
ATPase, class VI, type 11C |
|
increases expression |
ISO |
X |
145,746,536 |
145,861,055 |
RGD:6480464 |
CTD |
| G |
Atp11c |
ATPase, class VI, type 11C |
|
multiple interactions |
ISO |
X |
145,746,536 |
145,861,055 |
RGD:6480464 |
CTD |
| G |
Atp13a1 |
ATPase type 13A1 |
|
multiple interactions |
EXP |
16 |
20,100,481 |
20,116,536 |
RGD:6480464 |
CTD |
| G |
Atp13a4 |
ATPase type 13A4 |
|
decreases expression |
ISO |
11 |
73,163,802 |
73,251,192 |
RGD:6480464 |
CTD |
| G |
Atp13a4 |
ATPase type 13A4 |
|
multiple interactions |
ISO |
11 |
73,163,802 |
73,251,192 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
multiple interactions |
EXP |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp1a4 |
ATPase, Na+/K+ transporting, alpha 4 polypeptide |
|
decreases expression |
EXP |
13 |
88,213,848 |
88,249,075 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
multiple interactions |
EXP |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
increases expression |
EXP |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp1b3 |
ATPase, Na+/K+ transporting, beta 3 polypeptide |
|
decreases expression |
EXP |
8 |
101,405,877 |
101,437,757 |
RGD:6480464 |
CTD |
| G |
Atp2a1 |
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Atp2a1 |
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
|
multiple interactions |
EXP |
4 |
149,655,651 |
149,907,813 |
RGD:6480464 |
CTD |
| G |
Atp2c1 |
ATPase, Ca++ transporting, type 2C, member 1 |
|
multiple interactions |
EXP |
8 |
110,516,092 |
110,603,620 |
RGD:6480464 |
CTD |
| G |
Atr |
ataxia telangiectasia and Rad3 related |
|
multiple interactions |
ISO |
8 |
100,936,342 |
101,014,881 |
RGD:6480464 |
CTD |
| G |
Bcl2l2 |
Bcl2-like 2 |
|
multiple interactions |
ISO |
15 |
32,983,165 |
32,988,018 |
RGD:6480464 |
CTD |
| G |
Bcs1l |
BC1 (ubiquinol-cytochrome c reductase) synthesis-like |
|
multiple interactions |
EXP |
9 |
73,939,024 |
73,943,055 |
RGD:6480464 |
CTD |
| G |
Bdh1 |
3-hydroxybutyrate dehydrogenase, type 1 |
|
decreases expression |
EXP |
11 |
71,130,561 |
71,165,695 |
RGD:6480464 |
CTD |
| G |
Bdh2 |
3-hydroxybutyrate dehydrogenase, type 2 |
|
multiple interactions |
EXP |
2 |
232,765,049 |
232,785,694 |
RGD:6480464 |
CTD |
| G |
Bend5 |
BEN domain containing 5 |
|
increases expression |
EXP |
5 |
132,955,337 |
133,001,386 |
RGD:6480464 |
CTD |
| G |
Bex1 |
brain expressed, X-linked 1 |
|
increases expression |
EXP |
X |
123,527,737 |
123,529,133 |
RGD:6480464 |
CTD |
| G |
Bex4 |
brain expressed, X-linked 4 |
|
increases expression |
EXP |
X |
123,442,511 |
123,443,772 |
RGD:6480464 |
CTD |
| G |
Bex4 |
brain expressed, X-linked 4 |
|
multiple interactions |
EXP |
X |
123,442,511 |
123,443,772 |
RGD:6480464 |
CTD |
| G |
Bgn |
biglycan |
|
multiple interactions |
EXP |
X |
159,380,557 |
159,393,409 |
RGD:6480464 |
CTD |
| G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
affects response to substance |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Blnk |
B-cell linker |
|
multiple interactions |
EXP |
1 |
246,091,335 |
246,165,075 |
RGD:6480464 |
CTD |
| G |
Bloc1s2 |
biogenesis of lysosomal organelles complex-1, subunit 2 |
|
multiple interactions |
EXP |
1 |
249,086,242 |
249,093,298 |
RGD:6480464 |
CTD |
| G |
Bmp1 |
bone morphogenetic protein 1 |
|
multiple interactions |
EXP |
15 |
50,878,144 |
50,922,313 |
RGD:6480464 |
CTD |
| G |
Bmp1 |
bone morphogenetic protein 1 |
|
increases expression |
EXP |
15 |
50,878,144 |
50,922,313 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
multiple interactions |
EXP |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bok |
BCL2-related ovarian killer |
|
multiple interactions |
EXP |
9 |
92,970,069 |
92,980,974 |
RGD:6480464 |
CTD |
| G |
Bphl |
biphenyl hydrolase-like (serine hydrolase) |
|
multiple interactions |
EXP |
17 |
37,143,275 |
37,181,166 |
RGD:6480464 |
CTD |
| G |
Braf |
v-raf murine sarcoma viral oncogene homolog B1 |
|
increases mutagenesis |
ISO |
4 |
67,117,759 |
67,243,058 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
increases expression |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
multiple interactions |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brca2 |
breast cancer 2, early onset |
|
increases expression |
ISO |
12 |
4,282,952 |
4,323,693 |
RGD:6480464 |
CTD |
| G |
Brca2 |
breast cancer 2, early onset |
|
multiple interactions |
ISO |
12 |
4,282,952 |
4,323,693 |
RGD:6480464 |
CTD |
| G |
Bri3 |
brain protein I3 |
|
decreases expression |
EXP |
12 |
10,670,023 |
10,678,698 |
RGD:6480464 |
CTD |
| G |
Bspry |
B-box and SPRY domain containing |
|
multiple interactions |
EXP |
5 |
79,471,061 |
79,493,239 |
RGD:6480464 |
CTD |
| G |
Bst2 |
bone marrow stromal cell antigen 2 |
|
increases expression |
ISO |
16 |
18,698,545 |
18,701,768 |
RGD:6480464 |
CTD |
| G |
Bst2 |
bone marrow stromal cell antigen 2 |
|
multiple interactions |
ISO |
16 |
18,698,545 |
18,701,768 |
RGD:6480464 |
CTD |
| G |
Btf3 |
basic transcription factor 3 |
|
multiple interactions |
EXP |
2 |
28,900,451 |
28,907,561 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
decreases response to substance |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
multiple interactions |
EXP |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
EXP |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
decreases expression |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btg3 |
BTG family, member 3 |
|
multiple interactions |
EXP |
11 |
17,241,627 |
17,257,740 |
RGD:6480464 |
CTD |
| G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
|
multiple interactions |
ISO |
3 |
115,323,510 |
115,354,906 |
RGD:6480464 |
CTD |
| G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
|
increases expression |
ISO |
3 |
115,323,510 |
115,354,906 |
RGD:6480464 |
CTD |
| G |
C1galt1 |
core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 |
|
multiple interactions |
EXP |
4 |
32,903,434 |
32,933,953 |
RGD:6480464 |
CTD |
| G |
C1qc |
complement component 1, q subcomponent, C chain |
|
multiple interactions |
ISO |
5 |
155,656,104 |
155,659,430 |
RGD:6480464 |
CTD |
| G |
C1qc |
complement component 1, q subcomponent, C chain |
|
increases expression |
EXP |
5 |
155,656,104 |
155,659,430 |
RGD:6480464 |
CTD |
| G |
C1qc |
complement component 1, q subcomponent, C chain |
|
increases expression |
ISO |
5 |
155,656,104 |
155,659,430 |
RGD:6480464 |
CTD |
| G |
C1s |
complement component 1, s subcomponent |
|
decreases expression |
EXP |
4 |
160,736,133 |
160,748,133 |
RGD:6480464 |
CTD |
| G |
C4bpa |
complement component 4 binding protein, alpha |
|
decreases expression |
ISO |
13 |
43,552,947 |
43,588,565 |
RGD:6480464 |
CTD |
| G |
C4bpb |
complement component 4 binding protein, beta |
|
decreases expression |
EXP |
13 |
43,598,158 |
43,608,875 |
RGD:6480464 |
CTD |
| G |
C5 |
complement component 5 |
|
decreases expression |
EXP |
3 |
14,011,115 |
14,102,744 |
RGD:6480464 |
CTD |
| G |
C6 |
complement component 6 |
|
decreases expression |
EXP |
2 |
53,691,290 |
53,764,539 |
RGD:6480464 |
CTD |
| G |
C9 |
complement component 9 |
|
decreases expression |
ISO |
2 |
55,743,084 |
55,791,148 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
increases expression |
EXP |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
multiple interactions |
EXP |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Cab39l |
calcium binding protein 39-like |
|
multiple interactions |
EXP |
15 |
38,552,234 |
38,640,594 |
RGD:6480464 |
CTD |
| G |
Cables1 |
Cdk5 and Abl enzyme substrate 1 |
|
decreases expression |
ISO |
18 |
3,425,890 |
3,529,998 |
RGD:6480464 |
CTD |
| G |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
|
multiple interactions |
EXP |
19 |
25,188,170 |
25,424,495 |
RGD:6480464 |
CTD |
| G |
Cacna2d1 |
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
|
multiple interactions |
EXP |
4 |
15,139,881 |
15,566,740 |
RGD:6480464 |
CTD |
| G |
Cacnb1 |
calcium channel, voltage-dependent, beta 1 subunit |
|
decreases expression |
EXP |
10 |
86,764,283 |
86,784,791 |
RGD:6480464 |
CTD |
| G |
Cacng5 |
calcium channel, voltage-dependent, gamma subunit 5 |
|
multiple interactions |
EXP |
10 |
97,300,594 |
97,309,023 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
multiple interactions |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
decreases expression |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Car5a |
carbonic anhydrase 5a, mitochondrial |
|
decreases expression |
ISO |
19 |
52,158,607 |
52,188,664 |
RGD:6480464 |
CTD |
| G |
Car5a |
carbonic anhydrase 5a, mitochondrial |
|
decreases expression |
EXP |
19 |
52,158,607 |
52,188,664 |
RGD:6480464 |
CTD |
| G |
Cblc |
Cbl proto-oncogene, E3 ubiquitin protein ligase C |
|
multiple interactions |
EXP |
1 |
79,091,412 |
79,108,189 |
RGD:6480464 |
CTD |
| G |
Cbr1 |
carbonyl reductase 1 |
|
increases expression |
ISO |
11 |
33,787,957 |
33,790,320 |
RGD:6480464 |
CTD |
| G |
Cbr1 |
carbonyl reductase 1 |
|
increases expression |
EXP |
11 |
33,787,957 |
33,790,320 |
RGD:6480464 |
CTD |
| G |
Cbs |
cystathionine beta synthase |
|
multiple interactions |
EXP |
20 |
10,047,478 |
10,075,520 |
RGD:6480464 |
CTD |
| G |
Cbs |
cystathionine beta synthase |
|
decreases expression |
EXP |
20 |
10,047,478 |
10,075,520 |
RGD:6480464 |
CTD |
| G |
Cbx3 |
chromobox homolog 3 |
|
increases expression |
EXP |
4 |
79,707,325 |
79,720,100 |
RGD:6480464 |
CTD |
| G |
Cbx5 |
chromobox homolog 5 |
|
multiple interactions |
ISO |
7 |
142,107,922 |
142,125,543 |
RGD:6480464 |
CTD |
| G |
Cbx5 |
chromobox homolog 5 |
|
increases expression |
ISO |
7 |
142,107,922 |
142,125,543 |
RGD:6480464 |
CTD |
| G |
Cbx6 |
chromobox homolog 6 |
|
multiple interactions |
EXP |
7 |
118,062,267 |
118,070,004 |
RGD:6480464 |
CTD |
| G |
Ccdc136 |
coiled-coil domain containing 136 |
|
increases expression |
ISO |
4 |
56,277,389 |
56,302,052 |
RGD:6480464 |
CTD |
| G |
Ccdc19 |
coiled-coil domain containing 19 |
|
multiple interactions |
EXP |
13 |
88,527,708 |
88,551,091 |
RGD:6480464 |
CTD |
| G |
Cckbr |
cholecystokinin B receptor |
|
multiple interactions |
EXP |
1 |
163,156,914 |
163,166,969 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl21 |
chemokine (C-C motif) ligand 21 |
|
increases expression |
EXP |
5 |
59,238,897 |
59,240,001 |
RGD:6480464 |
CTD |
| G |
Ccl21 |
chemokine (C-C motif) ligand 21 |
|
multiple interactions |
EXP |
5 |
59,238,897 |
59,240,001 |
RGD:6480464 |
CTD |
| G |
Ccl28 |
chemokine (C-C motif) ligand 28 |
|
decreases expression |
EXP |
2 |
51,688,294 |
51,712,931 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
multiple interactions |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
EXP |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccl6 |
chemokine (C-C motif) ligand 6 |
|
multiple interactions |
EXP |
10 |
71,660,623 |
71,665,255 |
RGD:6480464 |
CTD |
| G |
Ccl6 |
chemokine (C-C motif) ligand 6 |
|
multiple interactions |
EXP |
10 |
71,660,623 |
71,665,255 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
multiple interactions |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
multiple interactions |
EXP |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
increases expression |
EXP |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
ISO |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
EXP |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
multiple interactions |
EXP |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
increases expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
multiple interactions |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Ccnc |
cyclin C |
|
multiple interactions |
ISO |
5 |
36,465,490 |
36,483,538 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccndbp1 |
cyclin D-type binding-protein 1 |
|
decreases response to substance |
ISO |
3 |
107,787,374 |
107,800,798 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
multiple interactions |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
increases expression |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
multiple interactions |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
increases expression |
ISO |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Ccnf |
cyclin F |
|
multiple interactions |
ISO |
10 |
13,474,659 |
13,500,979 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
ISO |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
multiple interactions |
ISO |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdc6 |
cell division cycle 6 |
|
increases expression |
ISO |
10 |
87,684,493 |
87,697,865 |
RGD:6480464 |
CTD |
| G |
Cdca3 |
cell division cycle associated 3 |
|
multiple interactions |
ISO |
4 |
160,952,986 |
160,956,574 |
RGD:6480464 |
CTD |
| G |
Cdca3 |
cell division cycle associated 3 |
|
increases expression |
ISO |
4 |
160,952,986 |
160,956,574 |
RGD:6480464 |
CTD |
| G |
Cdca7 |
cell division cycle associated 7 |
|
increases expression |
ISO |
3 |
54,948,493 |
54,959,128 |
RGD:6480464 |
CTD |
| G |
Cdca7 |
cell division cycle associated 7 |
|
multiple interactions |
ISO |
3 |
54,948,493 |
54,959,128 |
RGD:6480464 |
CTD |
| G |
Cdca8 |
cell division cycle associated 8 |
|
increases expression |
ISO |
5 |
144,251,164 |
144,276,352 |
RGD:6480464 |
CTD |
| G |
Cdca8 |
cell division cycle associated 8 |
|
multiple interactions |
ISO |
5 |
144,251,164 |
144,276,352 |
RGD:6480464 |
CTD |
| G |
Cdca8 |
cell division cycle associated 8 |
|
multiple interactions |
EXP |
5 |
144,251,164 |
144,276,352 |
RGD:6480464 |
CTD |
| G |
Cdh11 |
cadherin 11 |
|
multiple interactions |
EXP |
19 |
2,225,209 |
2,382,805 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
multiple interactions |
EXP |
19 |
48,507,173 |
49,575,123 |
RGD:6480464 |
CTD |
| G |
Cdh17 |
cadherin 17 |
|
multiple interactions |
EXP |
5 |
26,047,222 |
26,099,173 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
multiple interactions |
EXP |
18 |
8,048,920 |
8,267,974 |
RGD:6480464 |
CTD |
| G |
Cdh3 |
cadherin 3 |
|
multiple interactions |
EXP |
19 |
36,343,823 |
36,393,819 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
multiple interactions |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
multiple interactions |
EXP |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
multiple interactions |
EXP |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
EXP |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
multiple interactions |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
increases expression |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
increases expression |
EXP |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
multiple interactions |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2ap2 |
cyclin-dependent kinase 2 associated protein 2 |
|
multiple interactions |
ISO |
1 |
206,681,430 |
206,683,098 |
RGD:6480464 |
CTD |
| G |
Cdk2ap2 |
cyclin-dependent kinase 2 associated protein 2 |
|
increases expression |
ISO |
1 |
206,681,430 |
206,683,098 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
decreases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
decreases expression |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
increases expression |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
multiple interactions |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
EXP |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases expression |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
multiple interactions |
EXP |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Chrnb1 |
cholinergic receptor, nicotinic, beta 1 (muscle) |
|
multiple interactions |
EXP |
10 |
56,604,907 |
56,617,423 |
RGD:6480464 |
CTD |
| G |
Chrne |
cholinergic receptor, nicotinic, epsilon (muscle) |
|
multiple interactions |
EXP |
10 |
57,497,192 |
57,501,511 |
RGD:6480464 |
CTD |
| G |
Chst13 |
carbohydrate (chondroitin 4) sulfotransferase 13 |
|
decreases expression |
ISO |
4 |
124,571,623 |
124,584,842 |
RGD:6480464 |
CTD |
| G |
Chst4 |
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4 |
|
multiple interactions |
ISO |
19 |
39,900,812 |
39,909,464 |
RGD:6480464 |
CTD |
| G |
Chst8 |
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8 |
|
multiple interactions |
EXP |
1 |
87,152,490 |
87,311,536 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
increases activity |
ISO |
1 |
249,122,845 |
249,158,369 |
RGD:6480464 |
CTD |
| G |
Cib3 |
calcium and integrin binding family member 3 |
|
increases expression |
ISO |
16 |
18,046,964 |
18,055,850 |
RGD:6480464 |
CTD |
| G |
Cib3 |
calcium and integrin binding family member 3 |
|
multiple interactions |
ISO |
16 |
18,046,964 |
18,055,850 |
RGD:6480464 |
CTD |
| G |
Cirh1a |
cirrhosis, autosomal recessive 1A (cirhin) |
|
multiple interactions |
EXP |
19 |
36,742,206 |
36,770,285 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
increases expression |
ISO |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions |
ISO |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
multiple interactions |
EXP |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Cited4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
|
decreases expression |
ISO |
5 |
141,258,564 |
141,259,455 |
RGD:6480464 |
CTD |
| G |
Ckap2 |
cytoskeleton associated protein 2 |
|
increases expression |
ISO |
16 |
74,492,221 |
74,518,743 |
RGD:6480464 |
CTD |
| G |
Ckap2 |
cytoskeleton associated protein 2 |
|
multiple interactions |
ISO |
16 |
74,492,221 |
74,518,743 |
RGD:6480464 |
CTD |
| G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
|
increases expression |
ISO |
17 |
19,423,502 |
19,429,451 |
RGD:6480464 |
CTD |
| G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
|
multiple interactions |
ISO |
17 |
19,423,502 |
19,429,451 |
RGD:6480464 |
CTD |
| G |
Clcn1 |
chloride channel, voltage-sensitive 1 |
|
multiple interactions |
EXP |
4 |
70,052,319 |
70,081,449 |
RGD:6480464 |
CTD |
| G |
Clcn1 |
chloride channel, voltage-sensitive 1 |
|
increases expression |
EXP |
4 |
70,052,319 |
70,081,449 |
RGD:6480464 |
CTD |
| G |
Clcn5 |
chloride channel, voltage-sensitive 5 |
|
multiple interactions |
EXP |
X |
27,383,769 |
27,409,877 |
RGD:6480464 |
CTD |
| G |
Cldn1 |
claudin 1 |
|
multiple interactions |
EXP |
11 |
76,473,654 |
76,488,809 |
RGD:6480464 |
CTD |
| G |
Cldn1 |
claudin 1 |
|
multiple interactions |
EXP |
11 |
76,473,654 |
76,488,809 |
RGD:6480464 |
CTD |
| G |
Cldn16 |
claudin 16 |
|
increases expression |
ISO |
11 |
76,313,985 |
76,334,074 |
RGD:6480464 |
CTD |
| G |
Cldn7 |
claudin 7 |
|
multiple interactions |
EXP |
10 |
56,810,947 |
56,813,134 |
RGD:6480464 |
CTD |
| G |
Cldn7 |
claudin 7 |
|
multiple interactions |
EXP |
10 |
56,810,947 |
56,813,134 |
RGD:6480464 |
CTD |
| G |
Clec4a3 |
C-type lectin domain family 4, member A3 |
|
increases expression |
EXP |
4 |
159,464,410 |
159,474,023 |
RGD:6480464 |
CTD |
| G |
Clic2 |
chloride intracellular channel 2 |
|
increases expression |
EXP |
20 |
66,518 |
81,543 |
RGD:6480464 |
CTD |
| G |
Clic5 |
chloride intracellular channel 5 |
|
multiple interactions |
EXP |
9 |
12,370,341 |
12,472,969 |
RGD:6480464 |
CTD |
| G |
Clns1a |
chloride channel, nucleotide-sensitive, 1A |
|
multiple interactions |
EXP |
1 |
154,946,713 |
154,966,947 |
RGD:6480464 |
CTD |
| G |
Clock |
clock circadian regulator |
|
multiple interactions |
ISO |
14 |
34,218,472 |
34,258,054 |
RGD:6480464 |
CTD |
| G |
Clock |
clock circadian regulator |
|
increases response to substance |
ISO |
14 |
34,218,472 |
34,258,054 |
RGD:6480464 |
CTD |
| G |
Clock |
clock circadian regulator |
|
increases expression |
ISO |
14 |
34,218,472 |
34,258,054 |
RGD:6480464 |
CTD |
| G |
Clock |
clock circadian regulator |
|
multiple interactions |
ISO |
14 |
34,218,472 |
34,258,054 |
RGD:6480464 |
CTD |
| G |
Clock |
clock circadian regulator |
|
multiple interactions |
EXP |
14 |
34,218,472 |
34,258,054 |
RGD:6480464 |
CTD |
| G |
Clpx |
ClpX caseinolytic peptidase X homolog (E. coli) |
|
multiple interactions |
EXP |
8 |
69,530,991 |
69,572,018 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
multiple interactions |
EXP |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
multiple interactions |
EXP |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
multiple interactions |
EXP |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Clybl |
citrate lyase beta like |
|
multiple interactions |
EXP |
15 |
107,313,924 |
107,539,458 |
RGD:6480464 |
CTD |
| G |
Clybl |
citrate lyase beta like |
|
multiple interactions |
EXP |
15 |
107,313,924 |
107,539,458 |
RGD:6480464 |
CTD |
| G |
Cml3 |
camello-like 3 |
|
multiple interactions |
EXP |
4 |
119,964,411 |
119,966,307 |
RGD:6480464 |
CTD |
| G |
Cml5 |
camello-like 5 |
|
increases expression |
ISO |
4 |
119,981,266 |
120,006,794 |
RGD:6480464 |
CTD |
| G |
Cml5 |
camello-like 5 |
|
multiple interactions |
ISO |
4 |
119,981,266 |
120,006,794 |
RGD:6480464 |
CTD |
| G |
Cnn3 |
calponin 3, acidic |
|
multiple interactions |
EXP |
2 |
218,044,803 |
218,075,914 |
RGD:6480464 |
CTD |
| G |
Col16a1 |
collagen, type XVI, alpha 1 |
|
multiple interactions |
EXP |
5 |
149,072,905 |
149,126,350 |
RGD:6480464 |
CTD |
| G |
Col18a1 |
collagen, type XVIII, alpha 1 |
|
multiple interactions |
EXP |
20 |
11,920,816 |
11,982,468 |
RGD:6480464 |
CTD |
| G |
Col18a1 |
collagen, type XVIII, alpha 1 |
|
multiple interactions |
EXP |
20 |
11,920,816 |
11,982,468 |
RGD:6480464 |
CTD |
| G |
Col18a1 |
collagen, type XVIII, alpha 1 |
|
decreases expression |
EXP |
20 |
11,920,816 |
11,982,468 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
EXP |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
increases expression |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col27a1 |
collagen, type XXVII, alpha 1 |
|
multiple interactions |
EXP |
5 |
80,198,078 |
80,316,354 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
multiple interactions |
EXP |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Col4a1 |
collagen, type IV, alpha 1 |
|
increases expression |
EXP |
16 |
83,045,183 |
83,157,835 |
RGD:6480464 |
CTD |
| G |
Col4a2 |
collagen, type IV, alpha 2 |
|
increases expression |
ISO |
16 |
82,899,206 |
83,045,102 |
RGD:6480464 |
CTD |
| G |
Col5a2 |
collagen, type V, alpha 2 |
|
increases expression |
EXP |
9 |
44,374,113 |
44,525,086 |
RGD:6480464 |
CTD |
| G |
Col6a1 |
collagen, type VI, alpha 1 |
|
multiple interactions |
ISO |
20 |
12,320,102 |
12,338,500 |
RGD:6480464 |
CTD |
| G |
Col6a1 |
collagen, type VI, alpha 1 |
|
increases expression |
ISO |
20 |
12,320,102 |
12,338,500 |
RGD:6480464 |
CTD |
| G |
Col6a2 |
collagen, type VI, alpha 2 |
|
multiple interactions |
EXP |
20 |
12,436,783 |
12,464,512 |
RGD:6480464 |
CTD |
| G |
Colec12 |
collectin sub-family member 12 |
|
multiple interactions |
EXP |
18 |
996,297 |
1,188,288 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases response to substance |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases mutagenesis |
EXP |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
multiple interactions |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctrb1 |
chymotrypsinogen B1 |
|
increases expression |
EXP |
19 |
41,611,382 |
41,616,058 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
increases expression |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
multiple interactions |
EXP |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsc |
cathepsin C |
|
decreases expression |
ISO |
1 |
144,629,802 |
144,661,183 |
RGD:6480464 |
CTD |
| G |
Ctsc |
cathepsin C |
|
multiple interactions |
ISO |
1 |
144,629,802 |
144,661,183 |
RGD:6480464 |
CTD |
| G |
Ctsc |
cathepsin C |
|
multiple interactions |
EXP |
1 |
144,629,802 |
144,661,183 |
RGD:6480464 |
CTD |
| G |
Ctsc |
cathepsin C |
|
multiple interactions |
EXP |
1 |
144,629,802 |
144,661,183 |
RGD:6480464 |
CTD |
| G |
Ctse |
cathepsin E |
|
increases expression |
EXP |
13 |
44,582,911 |
44,605,241 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
multiple interactions |
EXP |
2 |
190,394,854 |
190,405,668 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
ISO |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Ctsm |
cathepsin M |
|
multiple interactions |
EXP |
17 |
8,931,468 |
8,936,876 |
RGD:6480464 |
CTD |
| G |
Ctsr |
cathepsin R |
|
increases expression |
EXP |
17 |
9,235,486 |
9,244,251 |
RGD:6480464 |
CTD |
| G |
Ctsr |
cathepsin R |
|
multiple interactions |
EXP |
17 |
9,235,486 |
9,244,251 |
RGD:6480464 |
CTD |
| G |
Ctss |
cathepsin S |
|
increases expression |
ISO |
2 |
190,425,290 |
190,466,877 |
RGD:6480464 |
CTD |
| G |
Ctss |
cathepsin S |
|
multiple interactions |
ISO |
2 |
190,425,290 |
190,466,877 |
RGD:6480464 |
CTD |
| G |
Ctxn1 |
cortexin 1 |
|
decreases expression |
EXP |
12 |
1,531,822 |
1,533,433 |
RGD:6480464 |
CTD |
| G |
Cul5 |
cullin 5 |
|
multiple interactions |
EXP |
8 |
57,080,787 |
57,132,486 |
RGD:6480464 |
CTD |
| G |
Cuta |
cutA divalent cation tolerance homolog (E. coli) |
|
multiple interactions |
EXP |
20 |
5,175,113 |
5,176,689 |
RGD:6480464 |
CTD |
| G |
Cx3cl1 |
chemokine (C-X3-C motif) ligand 1 |
|
multiple interactions |
EXP |
19 |
10,666,940 |
10,676,424 |
RGD:6480464 |
CTD |
| G |
Cxadr |
coxsackie virus and adenovirus receptor |
|
increases expression |
EXP |
11 |
17,193,505 |
17,241,549 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl11 |
chemokine (C-X-C motif) ligand 11 |
|
multiple interactions |
EXP |
14 |
17,250,648 |
17,253,423 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
multiple interactions |
EXP |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
decreases expression |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
decreases expression |
EXP |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl16 |
chemokine (C-X-C motif) ligand 16 |
|
multiple interactions |
EXP |
10 |
57,296,126 |
57,300,721 |
RGD:6480464 |
CTD |
| G |
Cxcr3 |
chemokine (C-X-C motif) receptor 3 |
|
multiple interactions |
EXP |
X |
89,794,276 |
89,796,927 |
RGD:6480464 |
CTD |
| G |
Cyb5a |
cytochrome b5 type A (microsomal) |
|
multiple interactions |
ISO |
18 |
81,415,972 |
81,452,606 |
RGD:6480464 |
CTD |
| G |
Cyb5a |
cytochrome b5 type A (microsomal) |
|
increases expression |
ISO |
18 |
81,415,972 |
81,452,606 |
RGD:6480464 |
CTD |
| G |
Cyb5a |
cytochrome b5 type A (microsomal) |
|
multiple interactions |
EXP |
18 |
81,415,972 |
81,452,606 |
RGD:6480464 |
CTD |
| G |
Cyb5a |
cytochrome b5 type A (microsomal) |
|
multiple interactions |
ISO |
18 |
81,415,972 |
81,452,606 |
RGD:6480464 |
CTD |
| G |
Cyb5a |
cytochrome b5 type A (microsomal) |
|
decreases expression |
EXP |
18 |
81,415,972 |
81,452,606 |
RGD:6480464 |
CTD |
| G |
Cyb5a |
cytochrome b5 type A (microsomal) |
|
multiple interactions |
EXP |
18 |
81,415,972 |
81,452,606 |
RGD:6480464 |
CTD |
| G |
Cyb5a |
cytochrome b5 type A (microsomal) |
|
multiple interactions |
EXP |
18 |
81,415,972 |
81,452,606 |
RGD:6480464 |
CTD |
| G |
Cyb5b |
cytochrome b5 type B (outer mitochondrial membrane) |
|
multiple interactions |
ISO |
19 |
37,016,959 |
37,050,722 |
RGD:6480464 |
CTD |
| G |
Cyb5r3 |
cytochrome b5 reductase 3 |
|
multiple interactions |
EXP |
7 |
121,187,821 |
121,205,382 |
RGD:6480464 |
CTD |
| G |
Cyb5r4 |
cytochrome b5 reductase 4 |
|
decreases expression |
EXP |
8 |
92,278,453 |
92,343,490 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
multiple interactions |
EXP |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cyba |
cytochrome b-245, alpha polypeptide |
|
increases expression |
EXP |
19 |
52,713,150 |
52,721,609 |
RGD:6480464 |
CTD |
| G |
Cygb |
cytoglobin |
|
multiple interactions |
EXP |
10 |
106,759,885 |
106,769,651 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases activity |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
decreases activity |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp2c22 |
cytochrome P450, family 2, subfamily c, polypeptide 22 |
|
multiple interactions |
EXP |
1 |
245,298,381 |
245,339,035 |
RGD:6480464 |
CTD |
| G |
Cyp2c6v1 |
cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 |
|
decreases expression |
ISO |
1 |
243,859,015 |
243,896,003 |
RGD:6480464 |
CTD |
| G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c7 |
cytochrome P450, family 2, subfamily c, polypeptide 7 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c80 |
cytochrome P450, family 2, subfamily c, polypeptide 80 |
|
decreases expression |
EXP |
1 |
244,517,262 |
244,536,426 |
RGD:6480464 |
CTD |
| G |
Cyp2d2 |
cytochrome P450, family 2, subfamily d, polypeptide 2 |
|
decreases expression |
EXP |
7 |
120,796,210 |
120,800,279 |
RGD:6480464 |
CTD |
| G |
Cyp2d2 |
cytochrome P450, family 2, subfamily d, polypeptide 2 |
|
decreases expression |
EXP |
7 |
120,796,210 |
120,800,279 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
increases expression |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
multiple interactions |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
multiple interactions |
EXP |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
multiple interactions |
EXP |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
affects metabolic processing |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases activity |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases response to substance |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases response to substance |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
|
multiple interactions |
EXP |
1 |
82,191,741 |
82,204,629 |
RGD:6480464 |
CTD |
| G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
|
multiple interactions |
EXP |
1 |
82,191,741 |
82,204,629 |
RGD:6480464 |
CTD |
| G |
Cyp2j3 |
cytochrome P450, family 2, subfamily j, polypeptide 3 |
|
decreases expression |
EXP |
5 |
116,744,337 |
116,766,822 |
RGD:6480464 |
CTD |
| G |
Cyp2u1 |
cytochrome P450, family 2, subfamily u, polypeptide 1 |
|
multiple interactions |
EXP |
2 |
228,771,187 |
228,788,636 |
RGD:6480464 |
CTD |
| G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
|
decreases expression |
EXP |
12 |
9,086,752 |
9,136,606 |
RGD:6480464 |
CTD |
| G |
Cyp3a18 |
cytochrome P450, family 3, subfamily a, polypeptide 18 |
|
multiple interactions |
EXP |
12 |
9,086,752 |
9,136,606 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
multiple interactions |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
multiple interactions |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
decreases expression |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
multiple interactions |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp3a23/3a1 |
cytochrome P450, family 3, subfamily a, polypeptide 23/polypeptide 1 |
|
multiple interactions |
EXP |
12 |
9,567,120 |
9,595,974 |
RGD:6480464 |
CTD |
| G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
5 |
135,901,653 |
135,915,754 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
increases expression |
ISO |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
decreases expression |
EXP |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
|
multiple interactions |
EXP |
5 |
135,546,858 |
135,578,199 |
RGD:6480464 |
CTD |
| G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
|
multiple interactions |
EXP |
5 |
135,546,858 |
135,578,199 |
RGD:6480464 |
CTD |
| G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
|
multiple interactions |
EXP |
5 |
135,546,858 |
135,578,199 |
RGD:6480464 |
CTD |
| G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
|
multiple interactions |
ISO |
5 |
135,917,327 |
135,934,636 |
RGD:6480464 |
CTD |
| G |
Ddx56 |
DEAD (Asp-Glu-Ala-Asp) box helicase 56 |
|
multiple interactions |
EXP |
14 |
86,985,893 |
86,994,552 |
RGD:6480464 |
CTD |
| G |
Deaf1 |
DEAF1 transcription factor |
|
multiple interactions |
EXP |
1 |
201,491,091 |
201,524,767 |
RGD:6480464 |
CTD |
| G |
Defb1 |
defensin beta 1 |
|
increases expression |
EXP |
16 |
74,980,054 |
74,995,445 |
RGD:6480464 |
CTD |
| G |
Degs1 |
delta(4)-desaturase, sphingolipid 1 |
|
multiple interactions |
EXP |
13 |
98,242,981 |
98,249,638 |
RGD:6480464 |
CTD |
| G |
Dek |
DEK oncogene |
|
multiple interactions |
ISO |
17 |
23,633,551 |
23,655,507 |
RGD:6480464 |
CTD |
| G |
Dek |
DEK oncogene |
|
increases expression |
ISO |
17 |
23,633,551 |
23,655,507 |
RGD:6480464 |
CTD |
| G |
Dgkb |
diacylglycerol kinase, beta |
|
multiple interactions |
EXP |
6 |
56,715,327 |
57,479,656 |
RGD:6480464 |
CTD |
| G |
Dguok |
deoxyguanosine kinase |
|
increases expression |
ISO |
4 |
117,697,251 |
117,725,383 |
RGD:6480464 |
CTD |
| G |
Dguok |
deoxyguanosine kinase |
|
multiple interactions |
ISO |
4 |
117,697,251 |
117,725,383 |
RGD:6480464 |
CTD |
| G |
Dhfr |
dihydrofolate reductase |
|
multiple interactions |
EXP |
2 |
22,607,093 |
22,828,487 |
RGD:6480464 |
CTD |
| G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
|
multiple interactions |
EXP |
19 |
39,463,111 |
39,477,184 |
RGD:6480464 |
CTD |
| G |
Dhrs2 |
dehydrogenase/reductase (SDR family) member 2 |
|
decreases expression |
ISO |
15 |
33,286,599 |
33,337,467 |
RGD:6480464 |
CTD |
| G |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
|
decreases expression |
ISO |
5 |
163,341,856 |
163,375,604 |
RGD:6480464 |
CTD |
| G |
Dhrs7 |
dehydrogenase/reductase (SDR family) member 7 |
|
decreases expression |
EXP |
6 |
95,005,675 |
95,029,519 |
RGD:6480464 |
CTD |
| G |
Diablo |
diablo, IAP-binding mitochondrial protein |
|
multiple interactions |
EXP |
12 |
34,196,347 |
34,209,633 |
RGD:6480464 |
CTD |
| G |
Dio1 |
deiodinase, iodothyronine, type I |
|
multiple interactions |
EXP |
5 |
128,385,702 |
128,404,015 |
RGD:6480464 |
CTD |
| G |
Dio2 |
deiodinase, iodothyronine, type II |
|
multiple interactions |
EXP |
6 |
114,307,758 |
114,317,563 |
RGD:6480464 |
CTD |
| G |
Disc1 |
disrupted in schizophrenia 1 |
|
increases expression |
EXP |
19 |
55,265,116 |
55,449,375 |
RGD:6480464 |
CTD |
| G |
Disc1 |
disrupted in schizophrenia 1 |
|
multiple interactions |
EXP |
19 |
55,265,116 |
55,449,375 |
RGD:6480464 |
CTD |
| G |
Dmbt1 |
deleted in malignant brain tumors 1 |
|
increases expression |
EXP |
1 |
190,378,428 |
190,470,536 |
RGD:6480464 |
CTD |
| G |
Dmbt1 |
deleted in malignant brain tumors 1 |
|
multiple interactions |
EXP |
1 |
190,378,428 |
190,470,536 |
RGD:6480464 |
CTD |
| G |
Dmgdh |
dimethylglycine dehydrogenase |
|
decreases expression |
EXP |
2 |
23,976,563 |
24,052,766 |
RGD:6480464 |
CTD |
| G |
Dmgdh |
dimethylglycine dehydrogenase |
|
multiple interactions |
EXP |
2 |
23,976,563 |
24,052,766 |
RGD:6480464 |
CTD |
| G |
Dmrt1 |
doublesex and mab-3 related transcription factor 1 |
|
multiple interactions |
EXP |
1 |
228,936,606 |
229,036,885 |
RGD:6480464 |
CTD |
| G |
Dnah3 |
dynein, axonemal, heavy chain 3 |
|
multiple interactions |
EXP |
1 |
178,234,649 |
178,311,979 |
RGD:6480464 |
CTD |
| G |
Dnah5 |
dynein, axonemal, heavy chain 5 |
|
multiple interactions |
EXP |
2 |
80,126,196 |
80,390,674 |
RGD:6480464 |
CTD |
| G |
Dnaja1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
multiple interactions |
EXP |
5 |
58,100,794 |
58,111,705 |
RGD:6480464 |
CTD |
| G |
Dnaja1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
multiple interactions |
EXP |
5 |
58,100,794 |
58,111,705 |
RGD:6480464 |
CTD |
| G |
Dnaja2 |
DnaJ (Hsp40) homolog, subfamily A, member 2 |
|
multiple interactions |
EXP |
19 |
22,853,702 |
22,871,846 |
RGD:6480464 |
CTD |
| G |
Dnaja2 |
DnaJ (Hsp40) homolog, subfamily A, member 2 |
|
multiple interactions |
EXP |
19 |
22,853,702 |
22,871,846 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
multiple interactions |
ISO |
19 |
26,213,739 |
26,217,480 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
decreases expression |
ISO |
19 |
26,213,739 |
26,217,480 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
multiple interactions |
EXP |
19 |
26,213,739 |
26,217,480 |
RGD:6480464 |
CTD |
| G |
Dnajc9 |
DnaJ (Hsp40) homolog, subfamily C, member 9 |
|
increases expression |
ISO |
15 |
4,152,480 |
4,156,756 |
RGD:6480464 |
CTD |
| G |
Dnajc9 |
DnaJ (Hsp40) homolog, subfamily C, member 9 |
|
multiple interactions |
ISO |
15 |
4,152,480 |
4,156,756 |
RGD:6480464 |
CTD |
| G |
Dnm1 |
dynamin 1 |
|
multiple interactions |
ISO |
3 |
11,434,778 |
11,478,452 |
RGD:6480464 |
CTD |
| G |
Dnm1 |
dynamin 1 |
|
increases expression |
ISO |
3 |
11,434,778 |
11,478,452 |
RGD:6480464 |
CTD |
| G |
Dnm1 |
dynamin 1 |
|
multiple interactions |
EXP |
3 |
11,434,778 |
11,478,452 |
RGD:6480464 |
CTD |
| G |
Dnm1l |
dynamin 1-like |
|
multiple interactions |
EXP |
11 |
86,617,236 |
86,665,861 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
multiple interactions |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
decreases expression |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
multiple interactions |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
increases expression |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dock9 |
dedicator of cytokinesis 9 |
|
multiple interactions |
EXP |
15 |
106,629,808 |
106,787,895 |
RGD:6480464 |
CTD |
| G |
Dok1 |
docking protein 1 |
|
increases expression |
ISO |
4 |
117,242,746 |
117,245,209 |
RGD:6480464 |
CTD |
| G |
Dok1 |
docking protein 1 |
|
multiple interactions |
ISO |
4 |
117,242,746 |
117,245,209 |
RGD:6480464 |
CTD |
| G |
Dom3z |
DOM-3 homolog Z (C. elegans) |
|
multiple interactions |
EXP |
20 |
4,093,718 |
4,095,802 |
RGD:6480464 |
CTD |
| G |
Dpep1 |
dipeptidase 1 (renal) |
|
multiple interactions |
EXP |
19 |
53,503,467 |
53,518,440 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
multiple interactions |
EXP |
3 |
44,279,255 |
44,360,283 |
RGD:6480464 |
CTD |
| G |
Dpp7 |
dipeptidylpeptidase 7 |
|
multiple interactions |
EXP |
3 |
3,514,968 |
3,519,220 |
RGD:6480464 |
CTD |
| G |
Dpp7 |
dipeptidylpeptidase 7 |
|
increases expression |
EXP |
3 |
3,514,968 |
3,519,220 |
RGD:6480464 |
CTD |
| G |
Dpt |
dermatopontin |
|
multiple interactions |
EXP |
13 |
80,562,890 |
80,591,361 |
RGD:6480464 |
CTD |
| G |
Dpy30 |
dpy-30 homolog (C. elegans) |
|
multiple interactions |
EXP |
6 |
21,084,031 |
21,104,731 |
RGD:6480464 |
CTD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
multiple interactions |
EXP |
2 |
214,931,901 |
215,818,809 |
RGD:6480464 |
CTD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
multiple interactions |
EXP |
2 |
214,931,901 |
215,818,809 |
RGD:6480464 |
CTD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
decreases expression |
EXP |
2 |
214,931,901 |
215,818,809 |
RGD:6480464 |
CTD |
| G |
Dpys |
dihydropyrimidinase |
|
multiple interactions |
EXP |
7 |
75,368,238 |
75,446,160 |
RGD:6480464 |
CTD |
| G |
Dpys |
dihydropyrimidinase |
|
multiple interactions |
EXP |
7 |
75,368,238 |
75,446,160 |
RGD:6480464 |
CTD |
| G |
Dpys |
dihydropyrimidinase |
|
decreases expression |
EXP |
7 |
75,368,238 |
75,446,160 |
RGD:6480464 |
CTD |
| G |
Dpysl2 |
dihydropyrimidinase-like 2 |
|
increases expression |
EXP |
15 |
46,346,413 |
46,413,786 |
RGD:6480464 |
CTD |
| G |
Dtnb |
dystrobrevin, beta |
|
multiple interactions |
EXP |
6 |
26,542,148 |
26,742,199 |
RGD:6480464 |
CTD |
| G |
Dtymk |
deoxythymidylate kinase (thymidylate kinase) |
|
increases expression |
ISO |
9 |
93,065,333 |
93,074,168 |
RGD:6480464 |
CTD |
| G |
Dtymk |
deoxythymidylate kinase (thymidylate kinase) |
|
multiple interactions |
ISO |
9 |
93,065,333 |
93,074,168 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
multiple interactions |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
multiple interactions |
EXP |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp4 |
dual specificity phosphatase 4 |
|
decreases expression |
ISO |
16 |
61,109,626 |
61,119,981 |
RGD:6480464 |
CTD |
| G |
Eif3k |
eukaryotic translation initiation factor 3, subunit K |
|
multiple interactions |
EXP |
1 |
84,083,646 |
84,088,799 |
RGD:6480464 |
CTD |
| G |
Eif5a |
eukaryotic translation initiation factor 5A |
|
multiple interactions |
EXP |
10 |
56,760,289 |
56,764,689 |
RGD:6480464 |
CTD |
| G |
Elac2 |
elaC homolog 2 (E. coli) |
|
increases expression |
EXP |
10 |
51,290,317 |
51,313,106 |
RGD:6480464 |
CTD |
| G |
Elf1 |
E74-like factor 1 |
|
increases expression |
ISO |
15 |
60,793,794 |
60,835,189 |
RGD:6480464 |
CTD |
| G |
Eln |
elastin |
|
multiple interactions |
EXP |
12 |
23,033,657 |
23,077,043 |
RGD:6480464 |
CTD |
| G |
Elovl3 |
ELOVL fatty acid elongase 3 |
|
decreases expression |
ISO |
1 |
251,351,908 |
251,355,736 |
RGD:6480464 |
CTD |
| G |
Emp1 |
epithelial membrane protein 1 |
|
decreases expression |
ISO |
4 |
172,315,122 |
172,335,536 |
RGD:6480464 |
CTD |
| G |
Emp1 |
epithelial membrane protein 1 |
|
multiple interactions |
EXP |
4 |
172,315,122 |
172,335,536 |
RGD:6480464 |
CTD |
| G |
Emp1 |
epithelial membrane protein 1 |
|
increases expression |
EXP |
4 |
172,315,122 |
172,335,536 |
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
multiple interactions |
EXP |
2 |
27,720,805 |
27,733,168 |
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
increases expression |
EXP |
2 |
27,720,805 |
27,733,168 |
RGD:6480464 |
CTD |
| G |
Eng |
endoglin |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
multiple interactions |
EXP |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
multiple interactions |
EXP |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
increases expression |
EXP |
1 |
21,223,678 |
21,287,411 |
RGD:6480464 |
CTD |
| G |
Enpp2 |
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
|
decreases expression |
EXP |
7 |
91,295,824 |
91,377,850 |
RGD:6480464 |
CTD |
| G |
Enpp5 |
ectonucleotide pyrophosphatase/phosphodiesterase 5 |
|
multiple interactions |
EXP |
9 |
12,574,480 |
12,581,130 |
RGD:6480464 |
CTD |
| G |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
|
multiple interactions |
EXP |
3 |
3,564,380 |
3,569,801 |
RGD:6480464 |
CTD |
| G |
Entpd5 |
ectonucleoside triphosphate diphosphohydrolase 5 |
|
increases expression |
EXP |
6 |
108,439,822 |
108,469,756 |
RGD:6480464 |
CTD |
| G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
|
affects expression |
EXP |
9 |
108,303,607 |
108,426,942 |
RGD:6480464 |
CTD |
| G |
Epcam |
epithelial cell adhesion molecule |
|
multiple interactions |
EXP |
6 |
11,176,664 |
11,192,628 |
RGD:6480464 |
CTD |
| G |
Epcam |
epithelial cell adhesion molecule |
|
increases expression |
EXP |
6 |
11,176,664 |
11,192,628 |
RGD:6480464 |
CTD |
| G |
Epdr1 |
ependymin related protein 1 (zebrafish) |
|
multiple interactions |
EXP |
17 |
53,135,000 |
53,160,954 |
RGD:6480464 |
CTD |
| G |
Epdr1 |
ependymin related protein 1 (zebrafish) |
|
increases expression |
EXP |
17 |
53,135,000 |
53,160,954 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
ISO |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
multiple interactions |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
multiple interactions |
ISO |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
multiple interactions |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
multiple interactions |
EXP |
15 |
45,497,660 |
45,556,101 |
RGD:6480464 |
CTD |
| G |
Epor |
erythropoietin receptor |
|
increases expression |
ISO |
8 |
21,061,310 |
21,065,886 |
RGD:6480464 |
CTD |
| G |
Epor |
erythropoietin receptor |
|
multiple interactions |
ISO |
8 |
21,061,310 |
21,065,886 |
RGD:6480464 |
CTD |
| G |
Eps15 |
epidermal growth factor receptor pathway substrate 15 |
|
multiple interactions |
EXP |
5 |
130,639,805 |
130,739,014 |
RGD:6480464 |
CTD |
| G |
Erc1 |
ELKS/RAB6-interacting/CAST family member 1 |
|
increases expression |
EXP |
4 |
155,931,377 |
156,221,104 |
RGD:6480464 |
CTD |
| G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ercc2 |
excision repair cross-complementing rodent repair deficiency, complementation group 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ercc3 |
excision repair cross-complementing rodent repair deficiency, complementation group 3 |
|
multiple interactions |
EXP |
18 |
24,684,912 |
24,716,143 |
RGD:6480464 |
CTD |
| G |
Ercc3 |
excision repair cross-complementing rodent repair deficiency, complementation group 3 |
|
multiple interactions |
EXP |
18 |
24,684,912 |
24,716,143 |
RGD:6480464 |
CTD |
| G |
Ercc4 |
excision repair cross-complementing rodent repair deficiency, complementation group 4 |
|
multiple interactions |
ISO |
10 |
2,144,262 |
2,177,554 |
RGD:6480464 |
CTD |
| G |
Ercc5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 |
|
multiple interactions |
ISO |
9 |
43,248,023 |
43,293,196 |
RGD:6480464 |
CTD |
| G |
Ercc5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 |
|
increases expression |
ISO |
9 |
43,248,023 |
43,293,196 |
RGD:6480464 |
CTD |
| G |
Ercc5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 |
|
multiple interactions |
ISO |
9 |
43,248,023 |
43,293,196 |
RGD:6480464 |
CTD |
| G |
Erp27 |
endoplasmic reticulum protein 27 |
|
decreases expression |
ISO |
4 |
173,948,853 |
173,966,545 |
RGD:6480464 |
CTD |
| G |
Erp29 |
endoplasmic reticulum protein 29 |
|
multiple interactions |
EXP |
12 |
36,225,110 |
36,231,363 |
RGD:6480464 |
CTD |
| G |
Esm1 |
endothelial cell-specific molecule 1 |
|
multiple interactions |
EXP |
2 |
44,626,010 |
44,634,748 |
RGD:6480464 |
CTD |
| G |
Espn |
espin |
|
decreases expression |
ISO |
5 |
169,349,723 |
169,382,076 |
RGD:6480464 |
CTD |
| G |
Etnk1 |
ethanolamine kinase 1 |
|
multiple interactions |
EXP |
4 |
181,060,600 |
181,104,724 |
RGD:6480464 |
CTD |
| G |
Ets1 |
v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
|
multiple interactions |
EXP |
8 |
32,481,694 |
32,545,237 |
RGD:6480464 |
CTD |
| G |
Ets2 |
v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) |
|
affects expression |
ISO |
11 |
36,014,047 |
36,030,833 |
RGD:6480464 |
CTD |
| G |
Ets2 |
v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) |
|
increases expression |
ISO |
11 |
36,014,047 |
36,030,833 |
RGD:6480464 |
CTD |
| G |
Etv4 |
ets variant 4 |
|
increases expression |
ISO |
10 |
90,808,439 |
90,824,019 |
RGD:6480464 |
CTD |
| G |
Etv4 |
ets variant 4 |
|
multiple interactions |
ISO |
10 |
90,808,439 |
90,824,019 |
RGD:6480464 |
CTD |
| G |
Exoc8 |
exocyst complex component 8 |
|
increases expression |
ISO |
19 |
55,066,272 |
55,068,761 |
RGD:6480464 |
CTD |
| G |
Exoc8 |
exocyst complex component 8 |
|
multiple interactions |
ISO |
19 |
55,066,272 |
55,068,761 |
RGD:6480464 |
CTD |
| G |
Exosc5 |
exosome component 5 |
|
multiple interactions |
EXP |
1 |
80,871,353 |
80,876,329 |
RGD:6480464 |
CTD |
| G |
Exosc7 |
exosome component 7 |
|
multiple interactions |
EXP |
8 |
127,868,051 |
127,893,391 |
RGD:6480464 |
CTD |
| G |
Ezh2 |
enhancer of zeste homolog 2 (Drosophila) |
|
increases expression |
ISO |
4 |
75,709,959 |
75,773,279 |
RGD:6480464 |
CTD |
| G |
Ezh2 |
enhancer of zeste homolog 2 (Drosophila) |
|
multiple interactions |
ISO |
4 |
75,709,959 |
75,773,279 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
multiple interactions |
EXP |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
multiple interactions |
EXP |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
increases expression |
EXP |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
F10 |
coagulation factor X |
|
decreases expression |
EXP |
16 |
81,327,237 |
81,346,544 |
RGD:6480464 |
CTD |
| G |
F5 |
coagulation factor V (proaccelerin, labile factor) |
|
multiple interactions |
EXP |
13 |
79,934,956 |
79,997,285 |
RGD:6480464 |
CTD |
| G |
Faah |
fatty acid amide hydrolase |
|
decreases expression |
EXP |
5 |
136,310,965 |
136,329,817 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
decreases expression |
EXP |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
multiple interactions |
EXP |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
EXP |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
increases expression |
ISO |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fkbp11 |
FK506 binding protein 11 |
|
increases expression |
EXP |
7 |
137,490,985 |
137,494,418 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
multiple interactions |
EXP |
20 |
6,637,478 |
6,686,768 |
RGD:6480464 |
CTD |
| G |
Flt1 |
FMS-related tyrosine kinase 1 |
|
decreases expression |
EXP |
12 |
7,858,092 |
8,035,966 |
RGD:6480464 |
CTD |
| G |
Flt1 |
FMS-related tyrosine kinase 1 |
|
increases expression |
EXP |
12 |
7,858,092 |
8,035,966 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
multiple interactions |
EXP |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
multiple interactions |
EXP |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
multiple interactions |
EXP |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
decreases expression |
EXP |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fmo2 |
flavin containing monooxygenase 2 |
|
multiple interactions |
EXP |
13 |
78,546,315 |
78,592,870 |
RGD:6480464 |
CTD |
| G |
Fmo2 |
flavin containing monooxygenase 2 |
|
multiple interactions |
EXP |
13 |
78,546,315 |
78,592,870 |
RGD:6480464 |
CTD |
| G |
Fmo3 |
flavin containing monooxygenase 3 |
|
increases expression |
ISO |
13 |
78,659,513 |
78,678,524 |
RGD:6480464 |
CTD |
| G |
Fmo3 |
flavin containing monooxygenase 3 |
|
multiple interactions |
ISO |
13 |
78,659,513 |
78,678,524 |
RGD:6480464 |
CTD |
| G |
Fmo3 |
flavin containing monooxygenase 3 |
|
multiple interactions |
EXP |
13 |
78,659,513 |
78,678,524 |
RGD:6480464 |
CTD |
| G |
Fmo5 |
flavin containing monooxygenase 5 |
|
multiple interactions |
EXP |
2 |
192,463,087 |
192,489,803 |
RGD:6480464 |
CTD |
| G |
Fmo5 |
flavin containing monooxygenase 5 |
|
multiple interactions |
EXP |
2 |
192,463,087 |
192,489,803 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fndc1 |
fibronectin type III domain containing 1 |
|
multiple interactions |
EXP |
1 |
41,522,019 |
41,583,357 |
RGD:6480464 |
CTD |
| G |
Fndc3b |
fibronectin type III domain containing 3B |
|
multiple interactions |
EXP |
2 |
113,315,670 |
113,558,806 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
affects expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
multiple interactions |
EXP |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Foxd1 |
forkhead box D1 |
|
multiple interactions |
EXP |
2 |
28,944,067 |
28,945,665 |
RGD:6480464 |
CTD |
| G |
Foxj1 |
forkhead box J1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Foxm1 |
forkhead box M1 |
|
multiple interactions |
ISO |
4 |
165,383,666 |
165,394,688 |
RGD:6480464 |
CTD |
| G |
Foxm1 |
forkhead box M1 |
|
increases expression |
ISO |
4 |
165,383,666 |
165,394,688 |
RGD:6480464 |
CTD |
| G |
Foxm1 |
forkhead box M1 |
|
increases phosphorylation |
ISO |
4 |
165,383,666 |
165,394,688 |
RGD:6480464 |
CTD |
| G |
Foxm1 |
forkhead box M1 |
|
multiple interactions |
ISO |
4 |
165,383,666 |
165,394,688 |
RGD:6480464 |
CTD |
| G |
Foxm1 |
forkhead box M1 |
|
multiple interactions |
ISO |
4 |
165,383,666 |
165,394,688 |
RGD:6480464 |
CTD |
| G |
Foxq1 |
forkhead box Q1 |
|
multiple interactions |
EXP |
17 |
39,332,906 |
39,334,655 |
RGD:6480464 |
CTD |
| G |
Frmd6 |
FERM domain containing 6 |
|
multiple interactions |
EXP |
6 |
92,953,340 |
93,027,451 |
RGD:6480464 |
CTD |
| G |
Frzb |
frizzled-related protein |
|
multiple interactions |
EXP |
3 |
63,350,504 |
63,383,436 |
RGD:6480464 |
CTD |
| G |
Fstl1 |
follistatin-like 1 |
|
multiple interactions |
EXP |
11 |
64,681,814 |
64,735,673 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
decreases expression |
ISO |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Ftl |
ferritin, light polypeptide |
|
multiple interactions |
EXP |
1 |
95,929,248 |
95,931,092 |
RGD:6480464 |
CTD |
| G |
Ftl |
ferritin, light polypeptide |
|
multiple interactions |
EXP |
1 |
95,929,248 |
95,931,092 |
RGD:6480464 |
CTD |
| G |
Ftl |
ferritin, light polypeptide |
|
decreases expression |
ISO |
1 |
95,929,248 |
95,931,092 |
RGD:6480464 |
CTD |
| G |
Ftl |
ferritin, light polypeptide |
|
multiple interactions |
ISO |
1 |
95,929,248 |
95,931,092 |
RGD:6480464 |
CTD |
| G |
Fut2 |
fucosyltransferase 2 (secretor status included) |
|
multiple interactions |
EXP |
1 |
96,118,530 |
96,137,450 |
RGD:6480464 |
CTD |
| G |
Fut8 |
fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
|
decreases expression |
ISO |
6 |
99,871,195 |
100,010,833 |
RGD:6480464 |
CTD |
| G |
Fxyd1 |
FXYD domain-containing ion transport regulator 1 |
|
decreases expression |
EXP |
1 |
86,095,551 |
86,098,079 |
RGD:6480464 |
CTD |
| G |
G0s2 |
G0/G1switch 2 |
|
multiple interactions |
EXP |
13 |
109,121,297 |
109,122,209 |
RGD:6480464 |
CTD |
| G |
G0s2 |
G0/G1switch 2 |
|
multiple interactions |
EXP |
13 |
109,121,297 |
109,122,209 |
RGD:6480464 |
CTD |
| G |
G0s2 |
G0/G1switch 2 |
|
decreases expression |
EXP |
13 |
109,121,297 |
109,122,209 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
increases expression |
ISO |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
multiple interactions |
ISO |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pc |
glucose-6-phosphatase, catalytic subunit |
|
multiple interactions |
EXP |
10 |
90,393,531 |
90,403,485 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
multiple interactions |
EXP |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
increases expression |
EXP |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Gabrb1 |
gamma-aminobutyric acid (GABA) A receptor, beta 1 |
|
decreases expression |
EXP |
14 |
38,530,259 |
39,005,615 |
RGD:6480464 |
CTD |
| G |
Gabrg1 |
gamma-aminobutyric acid (GABA) A receptor, gamma 1 |
|
multiple interactions |
EXP |
14 |
39,878,182 |
39,951,391 |
RGD:6480464 |
CTD |
| G |
Gad2 |
glutamate decarboxylase 2 |
|
decreases expression |
EXP |
17 |
96,259,430 |
96,321,857 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
multiple interactions |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
decreases expression |
ISO |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
multiple interactions |
ISO |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
multiple interactions |
ISO |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
increases expression |
ISO |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
multiple interactions |
EXP |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
multiple interactions |
EXP |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
|
multiple interactions |
EXP |
7 |
10,289,073 |
10,291,102 |
RGD:6480464 |
CTD |
| G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
|
increases expression |
ISO |
17 |
19,230,896 |
19,232,641 |
RGD:6480464 |
CTD |
| G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
|
multiple interactions |
ISO |
17 |
19,230,896 |
19,232,641 |
RGD:6480464 |
CTD |
| G |
Gale |
UDP-galactose-4-epimerase |
|
increases expression |
EXP |
5 |
154,745,853 |
154,750,357 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
decreases expression |
EXP |
X |
89,448,873 |
89,456,812 |
RGD:6480464 |
CTD |
| G |
Gjb1 |
gap junction protein, beta 1 |
|
affects response to substance |
EXP |
X |
89,448,873 |
89,456,812 |
RGD:6480464 |
CTD |
| G |
Gjb2 |
gap junction protein, beta 2 |
|
increases expression |
EXP |
15 |
36,153,526 |
36,159,490 |
RGD:6480464 |
CTD |
| G |
Gjc2 |
gap junction protein, gamma 2 |
|
multiple interactions |
EXP |
10 |
45,480,937 |
45,488,651 |
RGD:6480464 |
CTD |
| G |
Gkn1 |
gastrokine 1 |
|
multiple interactions |
EXP |
4 |
121,496,151 |
121,501,439 |
RGD:6480464 |
CTD |
| G |
Gkn3 |
gastrokine 3 |
|
decreases expression |
ISO |
4 |
121,535,051 |
121,540,818 |
RGD:6480464 |
CTD |
| G |
Gkn3 |
gastrokine 3 |
|
multiple interactions |
ISO |
4 |
121,535,051 |
121,540,818 |
RGD:6480464 |
CTD |
| G |
Glo1 |
glyoxalase 1 |
|
increases expression |
ISO |
20 |
8,900,984 |
8,919,001 |
RGD:6480464 |
CTD |
| G |
Glo1 |
glyoxalase 1 |
|
multiple interactions |
ISO |
20 |
8,900,984 |
8,919,001 |
RGD:6480464 |
CTD |
| G |
Glrx3 |
glutaredoxin 3 |
|
multiple interactions |
EXP |
1 |
197,176,020 |
197,206,249 |
RGD:6480464 |
CTD |
| G |
Gls |
glutaminase |
|
multiple interactions |
EXP |
9 |
46,380,165 |
46,452,974 |
RGD:6480464 |
CTD |
| G |
Gls2 |
glutaminase 2 (liver, mitochondrial) |
|
multiple interactions |
EXP |
7 |
1,484,397 |
1,495,283 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Glyat |
glycine-N-acyltransferase |
|
decreases expression |
EXP |
1 |
215,653,254 |
215,666,991 |
RGD:6480464 |
CTD |
| G |
Gmds |
GDP-mannose 4, 6-dehydratase |
|
multiple interactions |
EXP |
17 |
38,461,733 |
39,016,771 |
RGD:6480464 |
CTD |
| G |
Gmnn |
geminin |
|
multiple interactions |
ISO |
17 |
47,372,316 |
47,380,559 |
RGD:6480464 |
CTD |
| G |
Gmnn |
geminin |
|
increases expression |
ISO |
17 |
47,372,316 |
47,380,559 |
RGD:6480464 |
CTD |
| G |
Gnal |
guanine nucleotide binding protein, alpha stimulating, olfactory type |
|
multiple interactions |
EXP |
18 |
63,595,606 |
63,735,803 |
RGD:6480464 |
CTD |
| G |
Gne |
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
|
multiple interactions |
EXP |
5 |
60,506,171 |
60,536,403 |
RGD:6480464 |
CTD |
| G |
Gng8 |
guanine nucleotide binding protein (G protein), gamma 8 |
|
multiple interactions |
EXP |
1 |
77,221,378 |
77,223,313 |
RGD:6480464 |
CTD |
| G |
Gnl3 |
guanine nucleotide binding protein-like 3 (nucleolar) |
|
multiple interactions |
EXP |
16 |
6,444,437 |
6,450,375 |
RGD:6480464 |
CTD |
| G |
Gnmt |
glycine N-methyltransferase |
|
decreases expression |
EXP |
9 |
10,127,092 |
10,130,444 |
RGD:6480464 |
CTD |
| G |
Golga2 |
golgin A2 |
|
multiple interactions |
EXP |
3 |
11,412,088 |
11,434,260 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
increases activity |
EXP |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
multiple interactions |
ISO |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Got1 |
glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) |
|
multiple interactions |
EXP |
1 |
247,324,285 |
247,347,553 |
RGD:6480464 |
CTD |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
multiple interactions |
EXP |
1 |
261,370,264 |
261,431,434 |
RGD:6480464 |
CTD |
| G |
Gpbar1 |
G protein-coupled bile acid receptor 1 |
|
multiple interactions |
EXP |
9 |
73,605,141 |
73,606,130 |
RGD:6480464 |
CTD |
| G |
Gpc3 |
glypican 3 |
|
multiple interactions |
EXP |
X |
139,192,115 |
139,560,649 |
RGD:6480464 |
CTD |
| G |
Gphn |
gephyrin |
|
multiple interactions |
EXP |
6 |
100,833,004 |
101,302,957 |
RGD:6480464 |
CTD |
| G |
Gphn |
gephyrin |
|
decreases expression |
EXP |
6 |
100,833,004 |
101,302,957 |
RGD:6480464 |
CTD |
| G |
Gpi |
glucose-6-phosphate isomerase |
|
multiple interactions |
EXP |
1 |
86,658,836 |
86,686,712 |
RGD:6480464 |
CTD |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
decreases expression |
EXP |
17 |
47,145,567 |
47,188,345 |
RGD:6480464 |
CTD |
| G |
Gpm6a |
glycoprotein m6a |
|
multiple interactions |
EXP |
16 |
39,670,748 |
39,783,384 |
RGD:6480464 |
CTD |
| G |
Gpm6b |
glycoprotein m6b |
|
multiple interactions |
EXP |
X |
48,746,584 |
48,788,414 |
RGD:6480464 |
CTD |
| G |
Gpnmb |
glycoprotein (transmembrane) nmb |
|
increases expression |
EXP |
4 |
77,161,352 |
77,182,624 |
RGD:6480464 |
CTD |
| G |
Gpr19 |
G protein-coupled receptor 19 |
|
multiple interactions |
EXP |
4 |
171,791,727 |
171,809,215 |
RGD:6480464 |
CTD |
| G |
Gpr56 |
G protein-coupled receptor 56 |
|
multiple interactions |
EXP |
19 |
10,438,332 |
10,475,607 |
RGD:6480464 |
CTD |
| G |
Gpr64 |
G protein-coupled receptor 64 |
|
multiple interactions |
EXP |
X |
55,585,378 |
55,658,340 |
RGD:6480464 |
CTD |
| G |
Gpr64 |
G protein-coupled receptor 64 |
|
decreases expression |
EXP |
X |
55,585,378 |
55,658,340 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
increases activity |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpt |
glutamic-pyruvate transaminase (alanine aminotransferase) |
|
multiple interactions |
EXP |
7 |
114,746,054 |
114,748,903 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
ISO |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
EXP |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
EXP |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
EXP |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
EXP |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
increases expression |
EXP |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
EXP |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
EXP |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
multiple interactions |
EXP |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
multiple interactions |
EXP |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
increases expression |
EXP |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Gpx6 |
glutathione peroxidase 6 |
|
multiple interactions |
EXP |
17 |
51,063,379 |
51,068,058 |
RGD:6480464 |
CTD |
| G |
Grb14 |
growth factor receptor bound protein 14 |
|
multiple interactions |
EXP |
3 |
46,832,380 |
46,952,670 |
RGD:6480464 |
CTD |
| G |
Gria1 |
glutamate receptor, ionotropic, AMPA 1 |
|
multiple interactions |
EXP |
10 |
42,613,359 |
42,616,610 |
RGD:6480464 |
CTD |
| G |
Grik2 |
glutamate receptor, ionotropic, kainate 2 |
|
multiple interactions |
EXP |
20 |
53,231,473 |
53,713,131 |
RGD:6480464 |
CTD |
| G |
Grik5 |
glutamate receptor, ionotropic, kainate 5 |
|
multiple interactions |
EXP |
1 |
80,313,801 |
80,384,390 |
RGD:6480464 |
CTD |
| G |
Grm7 |
glutamate receptor, metabotropic 7 |
|
multiple interactions |
EXP |
4 |
146,952,340 |
147,270,225 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
increases expression |
EXP |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
decreases expression |
EXP |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
multiple interactions |
EXP |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
increases expression |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
EXP |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstt2 |
glutathione S-transferase, theta 2 |
|
multiple interactions |
EXP |
20 |
13,221,696 |
13,225,367 |
RGD:6480464 |
CTD |
| G |
Gstt2 |
glutathione S-transferase, theta 2 |
|
increases expression |
EXP |
20 |
13,221,696 |
13,225,367 |
RGD:6480464 |
CTD |
| G |
Gtf2h1 |
general transcription factor IIH, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
97,352,251 |
97,380,298 |
RGD:6480464 |
CTD |
| G |
Gucy2c |
guanylate cyclase 2C |
|
multiple interactions |
EXP |
4 |
173,740,202 |
173,791,116 |
RGD:6480464 |
CTD |
| G |
Gulo |
gulonolactone (L-) oxidase |
|
decreases expression |
EXP |
15 |
45,410,685 |
45,434,014 |
RGD:6480464 |
CTD |
| G |
Gulo |
gulonolactone (L-) oxidase |
|
multiple interactions |
EXP |
15 |
45,410,685 |
45,434,014 |
RGD:6480464 |
CTD |
| G |
Gyg1 |
glycogenin 1 |
|
multiple interactions |
EXP |
2 |
105,264,657 |
105,307,070 |
RGD:6480464 |
CTD |
| G |
Gys2 |
glycogen synthase 2 |
|
decreases expression |
EXP |
4 |
179,984,036 |
180,018,819 |
RGD:6480464 |
CTD |
| G |
H19 |
H19, imprinted maternally expressed transcript (non-protein coding) |
|
increases expression |
ISO |
1 |
202,822,925 |
202,825,601 |
RGD:6480464 |
CTD |
| G |
H19 |
H19, imprinted maternally expressed transcript (non-protein coding) |
|
multiple interactions |
ISO |
1 |
202,822,925 |
202,825,601 |
RGD:6480464 |
CTD |
| G |
Haao |
3-hydroxyanthranilate 3,4-dioxygenase |
|
decreases expression |
EXP |
6 |
7,197,352 |
7,210,456 |
RGD:6480464 |
CTD |
| G |
Hadha |
hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit |
|
multiple interactions |
EXP |
6 |
26,173,798 |
26,191,433 |
RGD:6480464 |
CTD |
| G |
Hagh |
hydroxyacyl glutathione hydrolase |
|
decreases expression |
EXP |
10 |
14,106,047 |
14,117,459 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
multiple interactions |
EXP |
7 |
30,520,913 |
30,551,145 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
multiple interactions |
EXP |
7 |
30,520,913 |
30,551,145 |
RGD:6480464 |
CTD |
| G |
Hal |
histidine ammonia lyase |
|
decreases expression |
EXP |
7 |
30,520,913 |
30,551,145 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
decreases expression |
ISO |
1 |
85,978,120 |
85,980,059 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
multiple interactions |
ISO |
1 |
85,978,120 |
85,980,059 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
multiple interactions |
EXP |
1 |
85,978,120 |
85,980,059 |
RGD:6480464 |
CTD |
| G |
Hamp |
hepcidin antimicrobial peptide |
|
multiple interactions |
EXP |
1 |
85,978,120 |
85,980,059 |
RGD:6480464 |
CTD |
| G |
Hao1 |
hydroxyacid oxidase (glycolate oxidase) 1 |
|
decreases expression |
EXP |
3 |
122,506,916 |
122,564,012 |
RGD:6480464 |
CTD |
| G |
Hao2 |
hydroxyacid oxidase 2 (long chain) |
|
multiple interactions |
EXP |
2 |
193,532,833 |
193,557,229 |
RGD:6480464 |
CTD |
| G |
Hao2 |
hydroxyacid oxidase 2 (long chain) |
|
decreases expression |
EXP |
2 |
193,532,833 |
193,557,229 |
RGD:6480464 |
CTD |
| G |
Hapln4 |
hyaluronan and proteoglycan link protein 4 |
|
increases expression |
ISO |
16 |
19,816,321 |
19,824,506 |
RGD:6480464 |
CTD |
| G |
Hat1 |
histone acetyltransferase 1 |
|
increases expression |
ISO |
3 |
53,696,664 |
53,744,333 |
RGD:6480464 |
CTD |
| G |
Hat1 |
histone acetyltransferase 1 |
|
multiple interactions |
ISO |
3 |
53,696,664 |
53,744,333 |
RGD:6480464 |
CTD |
| G |
Hba1 |
hemoglobin, alpha 1 |
|
increases expression |
ISO |
10 |
15,584,360 |
15,585,215 |
RGD:6480464 |
CTD |
| G |
Hbb |
hemoglobin, beta |
|
multiple interactions |
EXP |
1 |
161,618,782 |
161,620,193 |
RGD:6480464 |
CTD |
| G |
Hcn4 |
hyperpolarization activated cyclic nucleotide-gated potassium channel 4 |
|
multiple interactions |
EXP |
8 |
62,629,828 |
62,667,248 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
multiple interactions |
ISO |
5 |
148,672,515 |
148,699,810 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
decreases expression |
ISO |
5 |
148,672,515 |
148,699,810 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
increases expression |
ISO |
5 |
148,672,515 |
148,699,810 |
RGD:6480464 |
CTD |
| G |
Hdac10 |
histone deacetylase 10 |
|
multiple interactions |
EXP |
7 |
127,423,736 |
127,428,838 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
multiple interactions |
EXP |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
multiple interactions |
EXP |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hddc3 |
HD domain containing 3 |
|
multiple interactions |
EXP |
1 |
136,161,425 |
136,163,710 |
RGD:6480464 |
CTD |
| G |
Hdgf |
hepatoma-derived growth factor |
|
multiple interactions |
EXP |
2 |
179,981,346 |
179,991,892 |
RGD:6480464 |
CTD |
| G |
Heph |
hephaestin |
|
increases expression |
EXP |
X |
84,033,540 |
84,138,728 |
RGD:6480464 |
CTD |
| G |
Herpud1 |
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
|
decreases expression |
EXP |
19 |
11,036,567 |
11,046,914 |
RGD:6480464 |
CTD |
| G |
Hes6 |
hairy and enhancer of split 6 (Drosophila) |
|
decreases expression |
EXP |
9 |
90,639,890 |
90,641,596 |
RGD:6480464 |
CTD |
| G |
Hexb |
hexosaminidase B |
|
multiple interactions |
EXP |
2 |
27,649,188 |
27,672,231 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
multiple interactions |
ISO |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
decreases expression |
ISO |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
increases expression |
ISO |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
multiple interactions |
ISO |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hgfac |
HGF activator |
|
multiple interactions |
ISO |
14 |
81,348,282 |
81,354,836 |
RGD:6480464 |
CTD |
| G |
Hgfac |
HGF activator |
|
decreases expression |
ISO |
14 |
81,348,282 |
81,354,836 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
EXP |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
EXP |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Higd2a |
HIG1 hypoxia inducible domain family, member 2A |
|
multiple interactions |
EXP |
17 |
16,083,853 |
16,084,777 |
RGD:6480464 |
CTD |
| G |
Hm13 |
histocompatibility 13 |
|
multiple interactions |
EXP |
3 |
143,020,648 |
143,059,566 |
RGD:6480464 |
CTD |
| G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
multiple interactions |
EXP |
13 |
109,063,491 |
109,089,468 |
RGD:6480464 |
CTD |
| G |
Hsd17b11 |
hydroxysteroid (17-beta) dehydrogenase 11 |
|
increases expression |
ISO |
14 |
6,859,573 |
6,891,511 |
RGD:6480464 |
CTD |
| G |
Hsd17b11 |
hydroxysteroid (17-beta) dehydrogenase 11 |
|
multiple interactions |
ISO |
14 |
6,859,573 |
6,891,511 |
RGD:6480464 |
CTD |
| G |
Hsd17b13 |
hydroxysteroid (17-beta) dehydrogenase 13 |
|
multiple interactions |
EXP |
14 |
6,901,197 |
6,915,871 |
RGD:6480464 |
CTD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
decreases expression |
EXP |
19 |
47,729,519 |
47,802,933 |
RGD:6480464 |
CTD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
multiple interactions |
EXP |
19 |
47,729,519 |
47,802,933 |
RGD:6480464 |
CTD |
| G |
Hsd17b6 |
hydroxysteroid (17-beta) dehydrogenase 6 |
|
multiple interactions |
EXP |
7 |
1,118,183 |
1,137,670 |
RGD:6480464 |
CTD |
| G |
Hsd3b |
3 beta-hydroxysteroid dehydrogenase/delta-5-delta-4 isomerase type II |
|
decreases expression |
EXP |
2 |
193,387,391 |
193,388,559 |
RGD:6480464 |
CTD |
| G |
Hsd3b |
3 beta-hydroxysteroid dehydrogenase/delta-5-delta-4 isomerase type II |
|
multiple interactions |
EXP |
2 |
193,387,391 |
193,388,559 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
multiple interactions |
EXP |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
multiple interactions |
EXP |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
increases expression |
EXP |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hsp90ab1 |
heat shock protein 90 alpha (cytosolic), class B member 1 |
|
increases expression |
EXP |
9 |
11,033,496 |
11,038,868 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
EXP |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
EXP |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
increases expression |
ISO |
20 |
3,955,274 |
3,957,748 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
increases expression |
ISO |
20 |
3,955,274 |
3,957,748 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
multiple interactions |
ISO |
20 |
3,955,274 |
3,957,748 |
RGD:6480464 |
CTD |
| G |
Hspa2 |
heat shock protein 2 |
|
increases expression |
ISO |
6 |
99,000,541 |
99,003,041 |
RGD:6480464 |
CTD |
| G |
Hspa2 |
heat shock protein 2 |
|
multiple interactions |
EXP |
6 |
99,000,541 |
99,003,041 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
decreases expression |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
multiple interactions |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb2 |
heat shock protein beta 2 |
|
multiple interactions |
EXP |
8 |
54,105,807 |
54,106,778 |
RGD:6480464 |
CTD |
| G |
Hspb2 |
heat shock protein beta 2 |
|
multiple interactions |
EXP |
8 |
54,105,807 |
54,106,778 |
RGD:6480464 |
CTD |
| G |
Hspbap1 |
Hspb associated protein 1 |
|
multiple interactions |
EXP |
11 |
66,774,152 |
66,828,789 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
increases expression |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
multiple interactions |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
multiple interactions |
EXP |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
decreases response to substance |
ISO |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
multiple interactions |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
multiple interactions |
EXP |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
multiple interactions |
EXP |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Hsph1 |
heat shock 105/110 protein 1 |
|
increases expression |
ISO |
12 |
5,794,645 |
5,811,453 |
RGD:6480464 |
CTD |
| G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
|
multiple interactions |
EXP |
1 |
99,563,187 |
99,577,802 |
RGD:6480464 |
CTD |
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
increases expression |
ISO |
15 |
55,463,743 |
55,532,293 |
RGD:6480464 |
CTD |
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
multiple interactions |
ISO |
15 |
55,463,743 |
55,532,293 |
RGD:6480464 |
CTD |
| G |
Htra2 |
HtrA serine peptidase 2 |
|
multiple interactions |
EXP |
4 |
117,262,206 |
117,265,368 |
RGD:6480464 |
CTD |
| G |
Hyou1 |
hypoxia up-regulated 1 |
|
multiple interactions |
EXP |
8 |
47,346,753 |
47,358,869 |
RGD:6480464 |
CTD |
| G |
Ica1 |
islet cell autoantigen 1 |
|
multiple interactions |
EXP |
4 |
33,680,878 |
33,830,443 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
multiple interactions |
ISO |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
increases expression |
ISO |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Id4 |
inhibitor of DNA binding 4 |
|
multiple interactions |
EXP |
17 |
22,525,292 |
22,527,861 |
RGD:6480464 |
CTD |
| G |
Id4 |
inhibitor of DNA binding 4 |
|
decreases expression |
EXP |
17 |
22,525,292 |
22,527,861 |
RGD:6480464 |
CTD |
| G |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
multiple interactions |
ISO |
1 |
135,876,052 |
135,895,373 |
RGD:6480464 |
CTD |
| G |
Idh2 |
isocitrate dehydrogenase 2 (NADP+), mitochondrial |
|
increases expression |
ISO |
1 |
135,876,052 |
135,895,373 |
RGD:6480464 |
CTD |
| G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
|
multiple interactions |
EXP |
17 |
72,557,196 |
72,563,149 |
RGD:6480464 |
CTD |
| G |
Idi1 |
isopentenyl-diphosphate delta isomerase 1 |
|
decreases expression |
EXP |
17 |
72,557,196 |
72,563,149 |
RGD:6480464 |
CTD |
| G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
multiple interactions |
EXP |
16 |
71,866,340 |
71,878,373 |
RGD:6480464 |
CTD |
| G |
Ier5 |
immediate early response 5 |
|
multiple interactions |
EXP |
13 |
70,058,818 |
70,060,910 |
RGD:6480464 |
CTD |
| G |
Ifna1 |
interferon, alpha 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ifna1 |
interferon, alpha 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ifnb1 |
interferon beta 1, fibroblast |
|
increases expression |
ISO |
5 |
107,837,628 |
107,838,182 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
affects response to substance |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifngr1 |
interferon gamma receptor 1 |
|
increases expression |
EXP |
1 |
14,846,369 |
14,864,804 |
RGD:6480464 |
CTD |
| G |
Ift88 |
intraflagellar transport 88 homolog (Chlamydomonas) |
|
increases response to substance |
ISO |
15 |
36,468,007 |
36,560,959 |
RGD:6480464 |
CTD |
| G |
Igbp1 |
immunoglobulin (CD79A) binding protein 1 |
|
multiple interactions |
EXP |
X |
88,490,498 |
88,507,054 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
affects expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1r1 |
interleukin 1 receptor, type I |
|
multiple interactions |
EXP |
9 |
39,434,910 |
39,473,552 |
RGD:6480464 |
CTD |
| G |
Il1r2 |
interleukin 1 receptor, type II |
|
increases expression |
ISO |
9 |
39,279,397 |
39,319,672 |
RGD:6480464 |
CTD |
| G |
Il1rap |
interleukin 1 receptor accessory protein |
|
decreases expression |
ISO |
11 |
76,092,252 |
76,222,576 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
EXP |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il2rb |
interleukin 2 receptor, beta |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Il4r |
interleukin 4 receptor |
|
decreases expression |
EXP |
1 |
184,612,903 |
184,637,863 |
RGD:6480464 |
CTD |
| G |
Il4r |
interleukin 4 receptor |
|
increases expression |
EXP |
1 |
184,612,903 |
184,637,863 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
affects expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases response to substance |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Imp4 |
IMP4, U3 small nucleolar ribonucleoprotein, homolog (yeast) |
|
multiple interactions |
EXP |
9 |
33,179,406 |
33,184,544 |
RGD:6480464 |
CTD |
| G |
Incenp |
inner centromere protein |
|
increases expression |
ISO |
1 |
212,326,516 |
212,352,859 |
RGD:6480464 |
CTD |
| G |
Incenp |
inner centromere protein |
|
multiple interactions |
ISO |
1 |
212,326,516 |
212,352,859 |
RGD:6480464 |
CTD |
| G |
Inhbb |
inhibin beta-B |
|
multiple interactions |
EXP |
13 |
32,170,987 |
32,176,689 |
RGD:6480464 |
CTD |
| G |
Inhbc |
inhibin beta C |
|
multiple interactions |
EXP |
7 |
67,315,295 |
67,328,764 |
RGD:6480464 |
CTD |
| G |
Inhbe |
inhibin beta E |
|
decreases expression |
EXP |
7 |
67,308,713 |
67,310,138 |
RGD:6480464 |
CTD |
| G |
Inpp5a |
inositol polyphosphate-5-phosphatase A |
|
multiple interactions |
EXP |
1 |
199,187,936 |
199,395,997 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
decreases expression |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Insig2 |
insulin induced gene 2 |
|
multiple interactions |
EXP |
13 |
33,331,951 |
33,345,132 |
RGD:6480464 |
CTD |
| G |
Insig2 |
insulin induced gene 2 |
|
multiple interactions |
EXP |
13 |
33,331,951 |
33,345,132 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
affects expression |
EXP |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
decreases expression |
EXP |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Insrr |
insulin receptor-related receptor |
|
multiple interactions |
EXP |
2 |
179,857,189 |
179,876,572 |
RGD:6480464 |
CTD |
| G |
Ip6k2 |
inositol hexakisphosphate kinase 2 |
|
increases expression |
EXP |
8 |
113,836,756 |
113,861,895 |
RGD:6480464 |
CTD |
| G |
Ip6k2 |
inositol hexakisphosphate kinase 2 |
|
multiple interactions |
EXP |
8 |
113,836,756 |
113,861,895 |
RGD:6480464 |
CTD |
| G |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
|
decreases expression |
ISO |
4 |
149,543,029 |
149,599,463 |
RGD:6480464 |
CTD |
| G |
Irak2 |
interleukin-1 receptor-associated kinase 2 |
|
multiple interactions |
ISO |
4 |
149,543,029 |
149,599,463 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
increases expression |
ISO |
10 |
39,220,600 |
39,227,602 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
multiple interactions |
EXP |
10 |
39,220,600 |
39,227,602 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
multiple interactions |
ISO |
10 |
39,220,600 |
39,227,602 |
RGD:6480464 |
CTD |
| G |
Irf7 |
interferon regulatory factor 7 |
|
multiple interactions |
EXP |
1 |
201,456,689 |
201,459,756 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
affects expression |
EXP |
9 |
81,585,251 |
81,638,071 |
RGD:6480464 |
CTD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
affects expression |
EXP |
16 |
83,379,987 |
83,404,220 |
RGD:6480464 |
CTD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
multiple interactions |
EXP |
16 |
83,379,987 |
83,404,220 |
RGD:6480464 |
CTD |
| G |
Irs3 |
insulin receptor substrate 3 |
|
multiple interactions |
EXP |
12 |
19,709,141 |
19,711,279 |
RGD:6480464 |
CTD |
| G |
Isg20 |
interferon stimulated exonuclease gene 20 |
|
multiple interactions |
EXP |
1 |
134,631,524 |
134,637,868 |
RGD:6480464 |
CTD |
| G |
Isg20 |
interferon stimulated exonuclease gene 20 |
|
increases expression |
EXP |
1 |
134,631,524 |
134,637,868 |
RGD:6480464 |
CTD |
| G |
Itga3 |
integrin, alpha 3 |
|
increases expression |
ISO |
10 |
83,728,710 |
83,759,576 |
RGD:6480464 |
CTD |
| G |
Itga6 |
integrin, alpha 6 |
|
increases expression |
EXP |
3 |
54,202,931 |
54,272,803 |
RGD:6480464 |
CTD |
| G |
Itga8 |
integrin, alpha 8 |
|
multiple interactions |
EXP |
17 |
86,427,191 |
86,649,268 |
RGD:6480464 |
CTD |
| G |
Itgb6 |
integrin, beta 6 |
|
multiple interactions |
EXP |
3 |
42,286,140 |
42,360,793 |
RGD:6480464 |
CTD |
| G |
Itih3 |
inter-alpha trypsin inhibitor, heavy chain 3 |
|
decreases expression |
EXP |
16 |
6,341,043 |
6,358,767 |
RGD:6480464 |
CTD |
| G |
Itln1 |
intelectin 1 (galactofuranose binding) |
|
increases expression |
ISO |
13 |
87,445,119 |
87,455,226 |
RGD:6480464 |
CTD |
| G |
Itm2c |
integral membrane protein 2C |
|
increases expression |
EXP |
9 |
84,611,756 |
84,625,391 |
RGD:6480464 |
CTD |
| G |
Itpkb |
inositol-trisphosphate 3-kinase B |
|
decreases expression |
ISO |
13 |
96,044,260 |
96,138,456 |
RGD:6480464 |
CTD |
| G |
Itpkb |
inositol-trisphosphate 3-kinase B |
|
multiple interactions |
EXP |
13 |
96,044,260 |
96,138,456 |
RGD:6480464 |
CTD |
| G |
Itpkb |
inositol-trisphosphate 3-kinase B |
|
multiple interactions |
ISO |
13 |
96,044,260 |
96,138,456 |
RGD:6480464 |
CTD |
| G |
Ivd |
isovaleryl-CoA dehydrogenase |
|
decreases expression |
EXP |
3 |
105,374,429 |
105,394,861 |
RGD:6480464 |
CTD |
| G |
Jam2 |
junctional adhesion molecule 2 |
|
multiple interactions |
EXP |
11 |
24,310,704 |
24,315,219 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
affects expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
increases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Klf12 |
Kruppel-like factor 12 |
|
increases expression |
ISO |
15 |
83,686,143 |
84,046,291 |
RGD:6480464 |
CTD |
| G |
Klf12 |
Kruppel-like factor 12 |
|
multiple interactions |
ISO |
15 |
83,686,143 |
84,046,291 |
RGD:6480464 |
CTD |
| G |
Klf3 |
Kruppel-like factor 3 (basic) |
|
multiple interactions |
EXP |
14 |
46,203,638 |
46,226,077 |
RGD:6480464 |
CTD |
| G |
Klhl17 |
kelch-like family member 17 |
|
multiple interactions |
EXP |
5 |
173,064,739 |
173,069,548 |
RGD:6480464 |
CTD |
| G |
Klkb1 |
kallikrein B, plasma 1 |
|
decreases expression |
EXP |
16 |
50,248,935 |
50,272,279 |
RGD:6480464 |
CTD |
| G |
Klre1 |
killer cell lectin-like receptor, family E, member 1 |
|
multiple interactions |
EXP |
4 |
166,857,685 |
166,864,221 |
RGD:6480464 |
CTD |
| G |
Kmo |
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
|
decreases expression |
EXP |
13 |
91,363,517 |
91,394,174 |
RGD:6480464 |
CTD |
| G |
Kpna2 |
karyopherin alpha 2 |
|
multiple interactions |
EXP |
10 |
96,342,214 |
96,352,613 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
increases expression |
EXP |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
Krt13 |
keratin 13 |
|
increases expression |
ISO |
10 |
89,057,240 |
89,061,150 |
RGD:6480464 |
CTD |
| G |
Krt13 |
keratin 13 |
|
decreases expression |
ISO |
10 |
89,057,240 |
89,061,150 |
RGD:6480464 |
CTD |
| G |
Krt13 |
keratin 13 |
|
multiple interactions |
ISO |
10 |
89,057,240 |
89,061,150 |
RGD:6480464 |
CTD |
| G |
Krt13 |
keratin 13 |
|
multiple interactions |
EXP |
10 |
89,057,240 |
89,061,150 |
RGD:6480464 |
CTD |
| G |
Krt14 |
keratin 14 |
|
multiple interactions |
EXP |
10 |
89,144,357 |
89,148,415 |
RGD:6480464 |
CTD |
| G |
Krt14 |
keratin 14 |
|
multiple interactions |
EXP |
10 |
89,144,357 |
89,148,415 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
multiple interactions |
EXP |
10 |
89,185,097 |
89,189,816 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
increases expression |
ISO |
10 |
89,185,097 |
89,189,816 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
multiple interactions |
EXP |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
increases expression |
EXP |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
multiple interactions |
EXP |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
increases expression |
EXP |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt20 |
keratin 20 |
|
multiple interactions |
EXP |
10 |
88,335,894 |
88,379,899 |
RGD:6480464 |
CTD |
| G |
Krt23 |
keratin 23 (histone deacetylase inducible) |
|
multiple interactions |
EXP |
10 |
88,420,780 |
88,436,791 |
RGD:6480464 |
CTD |
| G |
Krt5 |
keratin 5 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
multiple interactions |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
increases expression |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
multiple interactions |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
multiple interactions |
EXP |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
multiple interactions |
EXP |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
multiple interactions |
EXP |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
increases expression |
EXP |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
multiple interactions |
EXP |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt80 |
keratin 80 |
|
increases expression |
ISO |
7 |
140,096,091 |
140,115,890 |
RGD:6480464 |
CTD |
| G |
Krtcap2 |
keratinocyte associated protein 2 |
|
multiple interactions |
EXP |
2 |
181,417,284 |
181,421,280 |
RGD:6480464 |
CTD |
| G |
Kynu |
kynureninase |
|
multiple interactions |
EXP |
3 |
24,046,242 |
24,195,898 |
RGD:6480464 |
CTD |
| G |
Lactb2 |
lactamase, beta 2 |
|
multiple interactions |
EXP |
5 |
4,770,321 |
4,793,420 |
RGD:6480464 |
CTD |
| G |
Lalba |
lactalbumin, alpha |
|
multiple interactions |
EXP |
7 |
137,220,916 |
137,223,614 |
RGD:6480464 |
CTD |
| G |
Lama3 |
laminin, alpha 3 |
|
increases expression |
ISO |
18 |
4,030,463 |
4,121,355 |
RGD:6480464 |
CTD |
| G |
Lama5 |
laminin, alpha 5 |
|
multiple interactions |
EXP |
3 |
169,233,897 |
169,282,410 |
RGD:6480464 |
CTD |
| G |
Lamc1 |
laminin, gamma 1 |
|
increases expression |
EXP |
13 |
68,241,453 |
68,369,419 |
RGD:6480464 |
CTD |
| G |
Lamc2 |
laminin, gamma 2 |
|
increases expression |
ISO |
13 |
68,151,074 |
68,211,117 |
RGD:6480464 |
CTD |
| G |
Lamp2 |
lysosomal-associated membrane protein 2 |
|
multiple interactions |
EXP |
X |
6,908,285 |
6,951,772 |
RGD:6480464 |
CTD |
| G |
Lancl1 |
LanC lantibiotic synthetase component C-like 1 (bacterial) |
|
decreases expression |
ISO |
9 |
65,799,079 |
65,828,986 |
RGD:6480464 |
CTD |
| G |
Lancl1 |
LanC lantibiotic synthetase component C-like 1 (bacterial) |
|
multiple interactions |
ISO |
9 |
65,799,079 |
65,828,986 |
RGD:6480464 |
CTD |
| G |
Lancl1 |
LanC lantibiotic synthetase component C-like 1 (bacterial) |
|
multiple interactions |
EXP |
9 |
65,799,079 |
65,828,986 |
RGD:6480464 |
CTD |
| G |
Lat |
linker for activation of T cells |
|
increases expression |
EXP |
1 |
185,450,155 |
185,455,180 |
RGD:6480464 |
CTD |
| G |
Lbp |
lipopolysaccharide binding protein |
|
multiple interactions |
EXP |
3 |
149,016,605 |
149,043,530 |
RGD:6480464 |
CTD |
| G |
Lcat |
lecithin cholesterol acyltransferase |
|
decreases expression |
EXP |
19 |
35,781,507 |
35,784,966 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
increases expression |
ISO |
3 |
11,511,402 |
11,514,747 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
increases expression |
EXP |
1 |
97,403,077 |
97,412,547 |
RGD:6480464 |
CTD |
| G |
Ldhb |
lactate dehydrogenase B |
|
increases expression |
EXP |
4 |
180,061,567 |
180,079,473 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
multiple interactions |
EXP |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Lepr |
leptin receptor |
|
multiple interactions |
EXP |
5 |
122,320,075 |
122,503,449 |
RGD:6480464 |
CTD |
| G |
Leprel1 |
leprecan-like 1 |
|
increases expression |
ISO |
11 |
76,687,437 |
76,828,785 |
RGD:6480464 |
CTD |
| G |
Leprot |
leptin receptor overlapping transcript |
|
multiple interactions |
EXP |
5 |
122,315,510 |
122,327,920 |
RGD:6480464 |
CTD |
| G |
Lgals1 |
lectin, galactoside-binding, soluble, 1 |
|
multiple interactions |
EXP |
7 |
116,893,662 |
116,896,768 |
RGD:6480464 |
CTD |
| G |
Lgals2 |
lectin, galactoside-binding, soluble, 2 |
|
multiple interactions |
EXP |
7 |
116,811,332 |
116,817,822 |
RGD:6480464 |
CTD |
| G |
Lgals2 |
lectin, galactoside-binding, soluble, 2 |
|
increases expression |
EXP |
7 |
116,811,332 |
116,817,822 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
EXP |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lgals3bp |
lectin, galactoside-binding, soluble, 3 binding protein |
|
increases expression |
ISO |
10 |
108,388,185 |
108,397,523 |
RGD:6480464 |
CTD |
| G |
Lgals3bp |
lectin, galactoside-binding, soluble, 3 binding protein |
|
multiple interactions |
EXP |
10 |
108,388,185 |
108,397,523 |
RGD:6480464 |
CTD |
| G |
Lgals3bp |
lectin, galactoside-binding, soluble, 3 binding protein |
|
increases expression |
EXP |
10 |
108,388,185 |
108,397,523 |
RGD:6480464 |
CTD |
| G |
Lgals7 |
lectin, galactoside-binding, soluble, 7 |
|
increases expression |
ISO |
1 |
83,968,263 |
83,970,018 |
RGD:6480464 |
CTD |
| G |
Lgi1 |
leucine-rich, glioma inactivated 1 |
|
multiple interactions |
EXP |
1 |
242,593,236 |
242,634,141 |
RGD:6480464 |
CTD |
| G |
Lgmn |
legumain |
|
increases expression |
EXP |
6 |
126,668,905 |
126,694,866 |
RGD:6480464 |
CTD |
| G |
Lhfpl4 |
lipoma HMGIC fusion partner-like 4 |
|
increases expression |
EXP |
4 |
149,049,668 |
149,072,608 |
RGD:6480464 |
CTD |
| G |
Man1a1 |
mannosidase, alpha, class 1A, member 1 |
|
multiple interactions |
EXP |
20 |
32,582,507 |
32,766,761 |
RGD:6480464 |
CTD |
| G |
Man2c1 |
mannosidase, alpha, class 2C, member 1 |
|
multiple interactions |
EXP |
8 |
60,887,362 |
60,898,465 |
RGD:6480464 |
CTD |
| G |
Maoa |
monoamine oxidase A |
|
multiple interactions |
EXP |
X |
17,678,960 |
17,745,908 |
RGD:6480464 |
CTD |
| G |
Maob |
monoamine oxidase B |
|
multiple interactions |
EXP |
X |
17,553,529 |
17,657,852 |
RGD:6480464 |
CTD |
| G |
Maob |
monoamine oxidase B |
|
multiple interactions |
EXP |
X |
17,553,529 |
17,657,852 |
RGD:6480464 |
CTD |
| G |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
|
multiple interactions |
EXP |
3 |
145,758,939 |
145,760,532 |
RGD:6480464 |
CTD |
| G |
Map2k3 |
mitogen activated protein kinase kinase 3 |
|
multiple interactions |
EXP |
10 |
47,075,270 |
47,096,617 |
RGD:6480464 |
CTD |
| G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
|
multiple interactions |
ISO |
10 |
52,009,149 |
52,041,599 |
RGD:6480464 |
CTD |
| G |
Map2k5 |
mitogen activated protein kinase kinase 5 |
|
multiple interactions |
EXP |
8 |
67,313,472 |
67,542,723 |
RGD:6480464 |
CTD |
| G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
|
multiple interactions |
ISO |
12 |
1,545,407 |
1,552,353 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases expression |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
decreases response to substance |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
decreases expression |
EXP |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
EXP |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
EXP |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases expression |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk6 |
mitogen-activated protein kinase 6 |
|
decreases expression |
EXP |
8 |
80,212,726 |
80,236,362 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases activity |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases response to substance |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
EXP |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapkapk3 |
mitogen-activated protein kinase-activated protein kinase 3 |
|
multiple interactions |
EXP |
8 |
112,497,626 |
112,531,778 |
RGD:6480464 |
CTD |
| G |
Mapre1 |
microtubule-associated protein, RP/EB family, member 1 |
|
increases expression |
EXP |
3 |
144,120,532 |
144,148,856 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
multiple interactions |
EXP |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
multiple interactions |
EXP |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Mbd1 |
methyl-CpG binding domain protein 1 |
|
increases expression |
ISO |
18 |
71,068,257 |
71,082,734 |
RGD:6480464 |
CTD |
| G |
Mbl1 |
mannose-binding lectin (protein A) 1 |
|
multiple interactions |
EXP |
16 |
17,591,820 |
17,597,859 |
RGD:6480464 |
CTD |
| G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
decreases expression |
EXP |
1 |
233,978,931 |
233,983,824 |
RGD:6480464 |
CTD |
| G |
Mbp |
myelin basic protein |
|
multiple interactions |
EXP |
18 |
78,943,608 |
79,057,329 |
RGD:6480464 |
CTD |
| G |
Mcm2 |
minichromosome maintenance complex component 2 |
|
multiple interactions |
ISO |
4 |
122,977,522 |
122,991,934 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
multiple interactions |
EXP |
4 |
173,910,595 |
173,913,917 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
increases expression |
EXP |
4 |
173,910,595 |
173,913,917 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
multiple interactions |
EXP |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
multiple interactions |
EXP |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mgst2 |
microsomal glutathione S-transferase 2 |
|
multiple interactions |
EXP |
2 |
140,546,939 |
140,568,616 |
RGD:6480464 |
CTD |
| G |
Mgst2 |
microsomal glutathione S-transferase 2 |
|
multiple interactions |
EXP |
2 |
140,546,939 |
140,568,616 |
RGD:6480464 |
CTD |
| G |
Mid1ip1 |
MID1 interacting protein 1 |
|
multiple interactions |
EXP |
X |
24,205,679 |
24,207,860 |
RGD:6480464 |
CTD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
multiple interactions |
EXP |
20 |
13,191,986 |
13,192,851 |
RGD:6480464 |
CTD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
multiple interactions |
EXP |
20 |
13,191,986 |
13,192,851 |
RGD:6480464 |
CTD |
| G |
Mipep |
mitochondrial intermediate peptidase |
|
multiple interactions |
EXP |
15 |
39,871,329 |
39,990,743 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
increases expression |
ISO |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
increases expression |
ISO |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
multiple interactions |
ISO |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
multiple interactions |
ISO |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
multiple interactions |
EXP |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
multiple interactions |
EXP |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mknk2 |
MAP kinase-interacting serine/threonine kinase 2 |
|
multiple interactions |
EXP |
7 |
10,550,040 |
10,561,100 |
RGD:6480464 |
CTD |
| G |
Mlec |
malectin |
|
multiple interactions |
EXP |
12 |
42,729,870 |
42,740,346 |
RGD:6480464 |
CTD |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
multiple interactions |
EXP |
8 |
115,616,396 |
115,653,471 |
RGD:6480464 |
CTD |
| G |
Mlph |
melanophilin |
|
decreases expression |
ISO |
9 |
90,113,308 |
90,149,114 |
RGD:6480464 |
CTD |
| G |
Mmd |
monocyte to macrophage differentiation-associated |
|
multiple interactions |
EXP |
10 |
78,664,115 |
78,692,402 |
RGD:6480464 |
CTD |
| G |
Mme |
membrane metallo-endopeptidase |
|
multiple interactions |
EXP |
2 |
153,031,724 |
153,114,515 |
RGD:6480464 |
CTD |
| G |
Rpl17 |
ribosomal protein L17 |
|
increases expression |
ISO |
18 |
71,863,062 |
71,866,168 |
RGD:6480464 |
CTD |
| G |
Rpl17 |
ribosomal protein L17 |
|
multiple interactions |
ISO |
18 |
71,863,062 |
71,866,168 |
RGD:6480464 |
CTD |
| G |
Rps27l |
ribosomal protein S27-like |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
RT1-CE7 |
RT1 class I, locus CE7 |
|
decreases expression |
ISO |
20 |
3,410,094 |
3,413,041 |
RGD:6480464 |
CTD |
| G |
RT1-CE7 |
RT1 class I, locus CE7 |
|
multiple interactions |
ISO |
20 |
3,410,094 |
3,413,041 |
RGD:6480464 |
CTD |
| G |
Timm10b |
translocase of inner mitochondrial membrane 10 homolog B |
|
multiple interactions |
EXP |
1 |
163,369,731 |
163,372,577 |
RGD:6480464 |
CTD |
| G |
Tpm3 |
tropomyosin 3 |
|
increases expression |
EXP |
2 |
182,303,994 |
182,324,994 |
RGD:6480464 |
CTD |
Term paths to the root
|